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Nanotechnology—the manipulation of matter on a near-atomic scale to produce new structures, 
materials, and devices—offers the promise of unprecedented scientific advancement for many sec-
tors, such as medicine, consumer products, energy, materials, and manufacturing. Nanotechnology 
has the power not only to improve existing technologies, but to dramatically enhance the effective-
ness of new applications. 
Research on the potential applications of nanotechnology continues to expand rapidly worldwide. 
New nanotechnology consumer products emerge at a rate of three to four per week. Over the course 
of the next decade, nanotechnology could have a $1 trillion impact on the global economy and em-
ploy two million workers—half of them residing in the U.S. 
While nanomaterials present seemingly limitless possibilities, they bring with them new challeng-
es to understanding, predicting, and managing potential safety and health risks to workers. The 
National Institute for Occupational Safety and Health (NIOSH) remains committed to protecting 
workers now and in the future, as nanotechnology applications and uses expand.
As part of these efforts, in October 2005, NIOSH released for public comment the draft document, 
Approaches to Safe Nanotechnology: An Information Exchange with NIOSH. Based on feedback 
received, NIOSH revised and updated the document in July 2006 and sought further public com-
ment. This draft report has been widely cited, and the final version of the report should serve as a 
vital resource for stakeholders (including occupational safety and health professionals, researchers, 
policy makers, risk assessors, and workers in the industry) who wish to understand more about the 
safety and health implications of nanotechnology in the workplace. 
With the publication of the Approaches to Safe Nanotechnology document, NIOSH hopes to: raise 
awareness of the occupational safety and health issues involved with nanotechnology; make recom-
mendations on occupational safety and health best practices in the production and use of nanoma-
terials; facilitate dialogue between NIOSH and its external partners in industry, labor and academia; 
respond to requests for authoritative safety and health guidelines; and, identify information gaps 
and areas for future study and research. 
As our knowledge of nanoscience increases, so too will our efforts to provide valuable guidance on 
the safe handling of nanoparticles and for protecting the lives and livelihoods of nanotechnology 
workers.
Christine M. Branche, Ph.D. 
Acting Director, National Institute  
   for Occupational Safety and Health 
Centers for Disease Control and Prevention
Foreword
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Nanotechnology has the potential to dra-
matically improve the effectiveness of a 
number of existing consumer and indus-
trial products and could have a substantial 
impact on the development of new prod-
ucts in all sectors, ranging from disease 
diagnosis and treatment to environmental 
remediation. Because of the broad range of 
possible nanotechnology applications, con-
tinued evaluation of the potential health 
risks associated with exposure to nanoma-
terials is essential to ensure their safe han-
dling. Engineered nanoparticles are materi-
als purposefully produced with at least one 
dimension between 1 and 100 nanometers. 
Nanoparticles* often exhibit unique physical 
and chemical properties that impart specific 
characteristics essential in making engi-
neered materials, but little is known about 
what effect these properties may have on 
human health. Research has shown that the 
physicochemical characteristics of particles 
can influence their effects in biological sys-
tems. These characteristics include particle 
size, shape, surface area, charge, chemical 
properties, solubility, oxidant generation 
potential, and degree of agglomeration. Un-
til the results from research studies can fully 
elucidate the characteristics of nanoparticles 
that may pose a health risk, precautionary 
measures are warranted. 
NIOSH has developed this document to 
provide an overview of what is known 
about the potential hazards of engineered 
*In an attempt at standardization of terminology, the In-
ternational Organization for Standardization-Technical 
Committee 229 has used the term nanomaterial to describe 
engineered nanoparticles.
nanoparticles and measures that can be 
taken to minimize workplace exposures. 
Following is a summary of findings and key 
recommendations.
Potential Health Concerns
The potential for nanomaterials to en-•	
ter the body is among several factors 
that scientists examine in determining 
whether such materials may pose an oc-
cupational health hazard. Nanomateri-
als have the greatest potential to enter 
the body through the respiratory sys-
tem if they are airborne and in the form 
of respirable-sized particles (nanopar-
ticles). They may also come into contact 
with the skin or be ingested. 
Based on results from human and ani-•	
mal studies, airborne nanoparticles can 
be inhaled and deposit in the respira-
tory tract; and based on animal stud-
ies, nanoparticles can enter the blood 
stream, and translocate to other organs.
Experimental studies in rats have shown •	
that equivalent mass doses of insolu-
ble incidental nanoparticles are more 
potent than large particles of similar 
composition in causing pulmonary in-
flammation and lung tumors. Results 
from in vitro cell culture studies with 
similar materials are generally support-
ive of the biological responses observed 
in animals.
Experimental studies in animals, cell •	
cultures, and cell-free systems have 
shown that changes in the chemical 
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composition, crystal structure, and size 
of particles can influence their oxidant 
generation properties and cytotoxicity. 
Studies in workers exposed to aerosols •	
of some manufactured or incidental 
microscopic (fine) and nanoscale (ul-
trafine) particles have reported adverse 
lung effects including lung function 
decrements and obstructive and fibrot-
ic lung diseases. The implications of 
these studies to engineered nanoparti-
cles, which may have different particle 
properties, are uncertain. 
Research is needed to determine the •	
key physical and chemical character-
istics of nanoparticles that determine 
their hazard potential. 
Potential Safety Concerns
Although insufficient information ex-•	
ists to predict the fire and explosion 
risk associated with powders of nano-
materials, nanoscale combustible ma-
terial could present a higher risk than 
coarser material with a similar mass 
concentration given its increased parti-
cle surface area and potentially unique 
properties due to the nanoscale. 
Some nanomaterials may initiate cat-•	
alytic reactions depending on their 
composition and structure that would 
not otherwise be anticipated based on 
their chemical composition.
Working with Engineered 
Nanomaterials
Nanomaterial-enabled products such as •	
nanocomposites, surface-coated mate-
rials, and materials comprised of nano-
structures, such as integrated circuits, 
are unlikely to pose a risk of exposure 
during their handling and use as ma-
terials of non-inhalable size. However, 
some of the processes used in their pro-
duction (e.g., formulating and applying 
nanoscale coatings) may lead to expo-
sure to nanomaterials, and the cutting 
or grinding of such products could re-
lease respirable-sized nanoparticles. 
Maintenance on production systems (in-•	
cluding cleaning and disposal of materi-
als from dust collection systems) is likely 
to result in exposure to nanoparticles if 
deposited nanomaterials are disturbed. 
The following workplace tasks can in-•	
crease the risk of exposure to nanopar-
ticles:
Working with nanomaterials in  —
liquid media without adequate 
protection (e.g., gloves)
Working with nanomaterials in  —
liquid during pouring or mixing 
operations, or where a high de-
gree of agitation is involved
Generating nanoparticles in non- —
enclosed systems 
Handling (e.g., weighing, blend- —
ing, spraying) powders of nano-
materials 
Maintenance on equipment and  —
processes used to produce or fabri-
cate nanomaterials and the clean-
ing-up of spills and waste material 
containing nanomaterials 
Cleaning of dust collection systems  —
used to capture nanoparticles 
Machining, sanding, drilling, or oth- —
er mechanical  disruptions of mate-
rials containing nanoparticles
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Exposure Assessment and 
Characterization
Until more information becomes avail-•	
able on the mechanisms underlying 
nanomaterial toxicity, it is uncertain what 
measurement technique should be used 
to monitor exposures in the workplace. 
Current research indicates that mass and 
bulk chemistry may be less important 
than particle size and shape, surface area, 
and surface chemistry (or activity) for 
some nanostructured materials. 
Many of the sampling techniques that •	
are available for measuring airborne 
nanoaerosols vary in complexity but can 
provide useful information for evaluat-
ing occupational exposures with respect 
to particle size, mass, surface area, num-
ber concentration, and composition. 
Unfortunately, relatively few of these 
techniques are readily applicable to rou-
tine exposure monitoring. NIOSH has 
initiated exposure assessment studies in 
workplaces that manufacture or use en-
gineered nanoparticles (see Appendix 
Nanoparticle Emission Assessment Tech-
nique for Identification of Sources and 
Releases of Engineered Nanomaterials).
Regardless of the metric or measurement •	
method used for evaluating nanoaerosol 
exposures, it is critical that background 
nanoscale particle measurements be 
conducted before the production, pro-
cessing, or handling of nanomaterials. 
When feasible, personal sampling is pre-•	
ferred to ensure an accurate representa-
tion of the worker’s exposure, whereas 
area sampling (e.g., size-fractionated 
aerosol samples) and real-time (direct 
reading) exposure measurements may 
be more useful for evaluating the need 
for improvement of engineering con-
trols and work practices.
Precautionary Measures
Given the limited amount of informa-•	
tion about health risks that may be as-
sociated with nanomaterials, taking 
measures to minimize worker exposures 
is prudent. 
For most processes and job tasks, the •	
control of airborne exposure to nano-
aerosols can be accomplished using a 
variety of engineering control tech-
niques similar to those used in reduc-
ing exposure to general aerosols.
The implementation of a risk manage-•	
ment program in workplaces where ex-
posure to nanomaterials exists can help 
to minimize the potential for exposure 
to nanoparticles. Elements of such a 
program should include the following:
Evaluating the hazard posed by the  —
nanomaterial based on available 
physical and chemical property 
data, toxicology, or health-effects 
data
Assessing the worker’s job task to  —
determine the potential for expo-
sure
Educating and training workers in  —
the proper handling of nanomate-
rials (e.g., good work practices)
Establishing criteria and proce- —
dures for installing and evaluat-
ing engineering controls (e.g., 
exhaust ventilation) at locations 
where exposure to nanomaterials 
might occur
viii Approaches to Safe Nanotechnology
Developing procedures for deter- —
mining the need for and selecting 
proper personal protective equip-
ment (e.g., clothing, gloves, respi-
rators)
Systematically evaluating expo- —
sures to ensure that control mea-
sures are working properly and 
that workers are being provided 
the appropriate personal protec-
tive equipment
Engineering control techniques such as •	
source enclosure (i.e., isolating the gen-
eration source from the worker) and lo-
cal exhaust ventilation systems should be 
effective for capturing airborne nano-
particles. Current knowledge indicates 
that a well-designed exhaust ventilation 
system with a high-efficiency particulate 
air (HEPA) filter should effectively re-
move nanomaterials.
The use of good work practices can •	
help to minimize worker exposures 
to nanomaterials. Examples of good 
practices include cleaning of work ar-
eas using HEPA vacuum pickup and 
wet wiping methods, preventing the 
consumption of food or beverages in 
workplaces where nanomaterials are 
handled, providing hand-washing fa-
cilities, and providing facilities for 
showering and changing clothes.
No guidelines are currently available on •	
the selection of clothing or other ap-
parel (e.g., gloves) for the prevention 
of dermal exposure to nanoaerosols. 
However, some clothing standards in-
corporate testing with nanometer-sized 
particles and therefore provide some in-
dication of the effectiveness of protec-
tive clothing.
Respirators may be necessary when en-•	
gineering and administrative controls 
do not adequately prevent exposures. 
Currently, there are no specific limits 
for airborne exposures to engineered 
nanoparticles although occupational 
exposure limits exist for some larger 
particles of similar chemical compo-
sition. It should be recognized that 
exposure limits recommended for non-
nanoscale particles may not be health 
protective for nanoparticle exposures 
(e.g., the OSHA Permissible Exposure 
Limit [PEL] for graphite may not be a 
safe exposure limit for carbon nano-
tubes). The decision to use respiratory 
protection should be based on profes-
sional judgment that takes into account 
toxicity information, exposure mea-
surement data, and the frequency and 
likelihood of the worker’s exposure. 
While research is continuing, prelimi-
nary evidence indicates that NIOSH-
certified respirators will be useful for 
protecting workers from nanoparticle 
inhalation when properly selected and 
fit tested as part of a complete respira-
tory protection program. 
Occupational Health 
Surveillance 
Occupational health surveillance is an essen-
tial component of an effective occupational 
safety and health program. The unique phys-
ical and chemical properties of nanomateri-
als, the increasing growth of nanotechnology 
in the workplace, and information suggesting 
that exposure to some engineered nanomate-
rials can cause adverse health effects in labo-
ratory animals all support consideration of 
an occupational health surveillance program 
for workers potentially exposed to engineered 
Executive Summary
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nanomaterials. Continued evaluation of tox-
icologic research and workers potentially ex-
posed to engineered nanomaterials is needed 
to inform NIOSH and other groups regarding 
the appropriate components of occupational 
health surveillance for nanotechnology work-
ers. NIOSH has formulated interim guidance 
relevant to medical screening (one compo-
nent of an occupational health surveillance 
program) for nanotechnology workers (see 
NIOSH Current Intelligence Bulletin Interim 
Guidance for Medical Screening and Hazard 
Surveillance for Workers Potentially Exposed 
to Engineered Nanoparticles at www.cdc.gov/
niosh/review/public/115/). In this document 
NIOSH concluded that insufficient scientific 
and medical evidence now exist to recom-
mend the specific medical screening of work-
ers potentially exposed to engineered nano-
particles. However, NIOSH did recommend 
that hazard surveillance be conducted as the 
basis for implementing control measures.
Executive Summary
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Nanotechnology is the manipulation of mat-
ter on a near-atomic scale to produce new 
structures, materials, and devices. This tech-
nology has the ability to transform many 
industries and can be applied in many ways 
to areas ranging from medicine to manufac-
turing. Research in nanoscale technologies 
is growing rapidly worldwide. Lux Research 
[2007] projects that new emerging nanotech-
nology applications will affect nearly every 
type of manufactured product through the 
middle of the next decade, becoming incor-
porated into 15% of global manufacturing 
output, totaling $2.6 trillion in 2014. 
Nanomaterials present new challenges to 
understanding, predicting, and managing 
potential health risks to workers. As with 
any material being developed, scientific data 
on the health effects in exposed workers are 
largely unavailable. In the case of nanoma-
terials, the uncertainties are great because 
the characteristics of nanoparticles may 
be different from those of larger particles 
with the same chemical composition. Safe-
ty and health practitioners recognize the 
critical lack of specific guidance on the safe 
handling of nanomaterials—especially now, 
when the degree of risk to exposed workers 
is unknown. In the meantime, the extensive 
scientific literature on airborne particles—
including toxicology and epidemiological 
studies, measurement techniques, and en-
gineering controls—provides the best avail-
able data from which to develop interim 
approaches for working safely with nano-
materials and to develop hypotheses for 
studies of new nanomaterials. 
The National Institute for Occupational 
Safety and Health (NIOSH) is working in 
parallel with the development and imple-
mentation of commercial nanotechnology 
through (1) conducting strategic planning 
and research, (2) partnering with public- 
and private-sector colleagues from the Unit-
ed States and abroad, and (3), making infor-
mation widely available. The NIOSH goal is 
to provide national and world leadership for 
incorporating research findings about the 
implications and applications of nanotech-
nology into good occupational safety and 
health practice for the benefit of all nano-
technology workers. NIOSH has developed 
a strategic plan for coordinating nanotech-
nology research and for use as a guide for en-
hancing the development of new research ef-
forts (www.cdc.gov/niosh/topics/nanotech/
strat_plan.html).
Introduction1
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With the publication of this Approaches to Safe 
Nanotechnology document, NIOSH hopes to 
do the following:
Raise awareness•	  of the occupational 
safety and health issues being identi-
fied in the rapidly moving and chang-
ing science involving implications and 
applications of nanotechnology.
Use the best information available to•	  
make recommendations on occupa-
tional safety and health practices in the 
production and use of nanomaterials 
(These recommendations will be updat-
ed as appropriate to reflect new informa-
tion. They will address key components 
of occupational safety and health, includ-
ing exposure monitoring, engineering 
controls, personal protective equipment, 
and administrative controls. They will 
draw from the ongoing NIOSH assess-
ment of current best practices, technical 
knowledge, and professional judgment. 
Throughout the development of these 
guidelines, the utility of a hazard-based 
approach to risk assessment and control 
was evaluated and, where appropriate, 
recommendations are provided.)
Facilitate an exchange of information •	
between NIOSH and its external partners 
from ongoing research, including success 
stories, applications, and case studies.
Respond to requests•	  from industry, la-
bor, academia, and other partners who 
are seeking science-based, authorita-
tive guidelines.
Identify information gaps•	  where few 
or no data exist and where research is 
needed. 
Purpose2
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This document has been developed to pro-
vide a resource for stakeholders who wish 
to understand more about the safety and 
health implications and applications of 
nanotechnology in the workplace. The in-
formation and guidelines presented here are 
intended to aid in evaluating the potential 
hazard of exposure to engineered nanoma-
terials and to set the stage for the develop-
ment of more comprehensive guidelines for 
reducing potential workplace exposures in 
the wide range of tasks and processes that 
use nanomaterials. The information in this 
document will be of specific interest to the 
following:
Occupational safety and health profes-•	
sionals who must (1) understand how 
nanotechnology may affect occupa-
tional health and (2) devise strategies 
for working safely with nanomaterials
Researchers working with or planning •	
to work with engineered nanomateri-
als and studying the potential occu-
pational safety and health impacts of 
nanomaterials
Policy and decision makers in govern-•	
ment agencies and industry
Risk evaluation professionals•	
People working with or potentially ex-•	
posed to engineered nanomaterials in 
the workplace
Established safe work practices are generally 
based on an understanding of the hazards 
associated with the chemical and physical 
properties of a material. Engineered nano-
materials may exhibit unique properties 
that are related to their physical size, shape, 
structure, and chemical composition. Con-
siderable uncertainty still exists as to whether 
these unique properties present occupational 
health risks. Current information about the 
potential adverse health effects of engineered 
nanomaterials, exposure assessment, and ex-
posure control is limited. However, the large 
body of scientific literature that exists on 
exposures to and responses of animals and 
humans to ultrafine and other airborne par-
ticles may be useful in making preliminary 
assessments as to the health risks posed by 
engineered nanomaterials. Until further in-
formation is available, interim safe work-
ing practices should be used based on the 
best available information. The information 
and recommendations in this document are 
intended to aid in assessment of the poten-
tial hazard of engineered nanomaterials and 
to set the stage for the development of more 
comprehensive guidelines for reducing po-
tential workplace exposures.
Scope3
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Nanotechnology involves the manipulation 
of matter at nanometer† scales to produce 
new materials, structures, and devices. The 
U.S. National Nanotechnology Initiative (see 
http://nano.gov/html/facts/whatIsNano.
html) defines a technology as nanotechnol-
ogy only if it involves all of the following: 
Research and technology development •	
involving structures with at least one 
dimension in the range of 1–100 nano-
meters (nm), frequently with atomic/
molecular precision
Creating and using structures, devices, •	
and systems that have unique prop-
erties and functions because of their 
nanoscale dimensions
The ability to control or manipulate on •	
the atomic scale
Nanotechnology is an enabling technology 
that offers the potential for unprecedented 
advances in many diverse fields. The abil-
ity to manipulate matter at the atomic or 
molecular scale makes it possible to form 
new materials, structures, and devices that 
exploit the unique physical and chemical 
properties associated with nanoscale struc-
tures. The promise of nanotechnology goes 
far beyond extending the use of current 
materials. New materials and devices with 
intricate and closely engineered structures 
will allow for (1) new directions in optics, 
electronics, and optoelectronics, (2) devel-
opment of new medical imaging and treat-
ment technologies, and (3) production of 
†1 nanometer (nm) = 1 billionth of a meter (10-9). 
advanced materials with unique properties 
and high-efficiency energy storage and gen-
eration.
Although nanotechnology-based products 
are generally thought to be at the precompet-
itive stage, an increasing number of products 
and materials are becoming commercially 
available. These include nanoscale powders, 
solutions, and suspensions of nanoscale ma-
terials as well as composite materials and 
devices having a nanostructure. Nanoscale 
products and materials are increasingly used 
in optoelectronic, electronic, magnetic, med-
ical imaging, drug delivery, cosmetic, cata-
lytic, and materials applications. New nano-
technology consumer products are coming 
on the market at the rate of three to four 
per week, a finding based on the latest up-
date to the nanotechnology consumer prod-
uct inventory maintained by the Project on 
Emerging Nanotechnologies (PEN)‡ (www.
nanotechproject.org/inventories/consumer). 
The number of consumer products using 
nanotechnology has grown from 212 to 609 
since PEN launched the world’s first online 
inventory of manufacturer-identified nano-
tech goods in March 2006. 
According to Lux Research [2007], in 2006, 
governments, corporations, and venture capi-
talists worldwide spent $11.8 billion on nano-
technology research and development (R&D), 
which was up 13% from 2005. By 2014, Lux 
estimates $2.6 trillion in manufactured goods 
‡The Project on Emerging Nanotechnologies was es-
tablished in April 2005 as a partnership between the 
Woodrow Wilson International Center for Scholars 
and the Pew Charitable Trusts.
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will incorporate nanotechnology—or about 
15% of total global output. 
4.1 Nano-objects 
The International Organization for Standard-
ization Technical Committee 229 (Nanotech-
nologies) is developing globally recognized 
nomenclature and terminology for nano-
materials. According to ISO/TS 27687:2008, 
nano-object is defined as material with one, 
two, or three external dimensions in the size 
range from approximately 1–100 nm. Sub-
categories of nano-object are (1) nanoplate, 
a nano-object with one external dimension 
at the nanoscale; (2) nanofiber, a nano-object 
with two external dimensions at the nano-
scale with a nanotube defined as a hollow 
nanofiber and a nanorod as a solid nanofiber; 
and (3) nanoparticle, a nano-object with all 
three external dimensions at the nanoscale. 
Nano-objects are commonly incorporated in 
a larger matrix or substrate referred to as a 
nanomaterial. Nano-objects may be suspend-
ed in a gas (as a nanoaerosol), suspended in a 
liquid (as a colloid or nanohydrosol), or em-
bedded in a matrix (as a nanocomposite). 
The precise definition of particle diameter 
depends on particle shape as well as how the 
diameter is measured. Particle morphologies 
may vary widely at the nanoscale. For in-
stance, carbon fullerenes represent nano-
 objects with identical dimensions in all 
directions (i.e., spherical), whereas sin-
gle-walled carbon nanotubes (SWCNTs) 
typically form convoluted, fiber-like nano-
objects. Many regular but nonspherical par-
ticle morphologies can be engineered at the 
nanoscale, including flower- and belt-like 
structures. Please see www.nanoscience.gat-
ech.edu/zlwang/research.html for examples 
of some nanoscale structures.
4.2 Ultrafine Particles
The term ultrafine particle has tradition-
ally been used by the aerosol research and 
occupational and environmental health 
communities to describe airborne particles 
smaller than 100 nm in diameter. Ultrafine 
is frequently used in the context of nano-
meter-diameter particles that have not been 
intentionally produced but are the inciden-
tal products of processes involving combus-
tion, welding, or diesel engines (see Figure 
4–1). The term nanoparticle is frequently 
used with respect to particles demonstrat-
ing size-dependent physicochemical prop-
erties, particularly from a materials science 
perspective. The two terms are sometimes 
used to differentiate between engineered 
Figure 4–1. Photomicrographs of airborne exposure to ultrafine (nanoscale) particles of 
welding fumes, diesel exhaust, and cerium oxide
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(nanoparticle) and incidental (ultrafine) 
nanoscale particles. 
It is currently unclear whether the use of 
source-based definitions of nanoparticles 
and ultrafine particles is justified from a safe-
ty and health perspective. This is particular-
ly the case where data on non- engineered, 
nanometer-diameter particles are of direct 
relevance to the impact of engineered par-
ticles. An attempt has been made in this 
document to follow the general convention 
of preferentially using nanoparticle in the 
context of intentionally produced or engi-
neered particles and ultrafine in the con-
text of incidentally produced particles (e.g., 
combustion products). However, this does 
not necessarily imply specific differences in 
the properties of these particles as related to 
hazard assessment, measurement, or con-
trol of exposures, and this remains an active 
area of research. Nanoparticle and ultrafine 
particle are not rigid definitions. For exam-
ple, since the term ultrafine has been in ex-
istence longer, some intentionally produced 
particles with primary particle sizes in the 
nanosize range (e.g., TiO
2
) are often called 
ultrafine in the literature.
4.3 Engineered Nanoparticles
Engineered nanoparticles are intentionally 
produced, whereas ultrafine particles (often 
referred to as incidental nanoparticles) are 
typically byproducts of processes such as 
combustion and vaporization. Engineered 
nanoparticles are designed with very spe-
cific properties or compositions (e.g., shape, 
size, surface properties, and chemistry). In-
cidental nanoparticles are generated in a rel-
atively uncontrolled manner and are usually 
physically and chemically heterogeneous 
compared with engineered nanoparticles.
4.4 Nanoaerosol
A nanoaerosol is a collection of nanopar-
ticles suspended in a gas. The particles may 
be present as discrete nano-objects, or as ag-
gregates or agglomerates of nano- objects. 
These agglomerates may have diameters 
larger than 100 nm. In the case of an aerosol 
consisting of micrometer- diameter particles 
formed as agglomerates of nano-objects, 
the definition of nanoaerosol is open to in-
terpretation. It is generally accepted that if 
the nanostructure associated with the nano-
object is accessible (through physical, chem-
ical, or biological interactions), then the 
aerosol may be considered a nanoaerosol. 
However, if the nanostructure within indi-
vidual micrometer-diameter particles does 
not directly influence particle behavior (for 
instance, if the nanoparticles were inaccessi-
bly embedded in a solid matrix), the aerosol 
would not be described as a nanoaerosol.
4.5 Agglomerate
An agglomerate is a group of nanoparticles 
held together by relatively weak forces, in-
cluding van der Waals forces, electrostatic 
forces, and surface tension [ISO 2006]. 
4.6 Aggregate
An aggregate is a heterogeneous particle in 
which the various components are held to-
gether by relatively strong forces, and thus 
not easily broken apart [ISO 2006]. Aggre-
gated nanoparticles would be an example of 
a nanostructured material.
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Nanotechnology is an emerging field. As 
such, there are many uncertainties as to 
whether the unique properties of engi-
neered nanomaterials (which underpin 
their commercial and scientific poten-
tial) also pose occupational health risks. 
These uncertainties arise because of gaps 
in knowledge about the factors that are es-
sential for predicting health risks—factors 
such as routes of exposure, translocation 
of materials once they enter the body, and 
interaction of the materials with the body’s 
biological systems. The potential health risk 
following exposure to a substance is gener-
ally associated with the magnitude and du-
ration of the exposure, the persistence of the 
material in the body, the inherent toxicity of 
the material, and the susceptibility or health 
status of the person exposed. More data are 
needed on the health risks associated with 
exposure to engineered nanomaterials. Re-
sults of existing studies in animals and hu-
mans on exposure and response to ultra-
fine or other respirable particles provide a 
basis for preliminary estimates of the pos-
sible adverse health effects from exposures 
to similar engineered materials on a nano-
scale. Experimental studies in rodents and 
cell cultures have shown that the toxicity 
of ultrafine or nanoparticles is greater than 
that of the same mass of larger particles of 
similar chemical composition [Oberdörster 
et al. 1992, 1994a, b; Lison et al. 1997; Tran 
et al. 1999, 2000; Brown et al. 2001; Barlow 
et al. 2005; Duffin et al. 2007]. In addition 
to particle surface area, other particle char-
acteristics may influence toxicity, includ-
ing surface functionalization or coatings, 
solubility, shape, and the ability to generate 
oxidant species and to adsorb biological 
proteins or bind to receptors [Duffin et al. 
2002; Oberdörster et al. 2005a; Maynard 
and Kuempel 2005; Donaldson et al. 2006]. 
More research is needed on the influence of 
particle properties on interactions with bio-
logical systems and the potential for adverse 
effects. International research strategies for 
evaluating the safety of nanomaterials are 
actively being developed through coopera-
tive efforts [Thomas et al. 2006].
Existing toxicity information about a given 
material of larger particle size can provide a 
baseline for anticipating the possible adverse 
health effects that may occur from exposure 
to a nanoscale material that has some of the 
same physicochemical properties (e.g., chem-
istry, density). However, predicting the toxic-
ity of an engineered nanomaterial based on 
its physicochemical properties may not pro-
vide an adequate level of protection. 
5.1 Exposure Routes 
Inhalation is the most common route of ex-
posure to airborne particles in the workplace. 
The deposition of discrete nano- objects in the 
respiratory tract is determined by the particle’s 
aerodynamic or thermodynamic diameter 
(i.e., the particle shape and size). Agglomer-
ates of nano-objects will deposit according to 
the diameter of the agglomerate, not constitu-
ent nano-objects. Research is ongoing to de-
termine the physical factors that contribute to 
the agglomeration and de-agglomeration of 
nano-objects in air, suspended in aqueous me-
dia, or once in contact with lung lining fluid 
and/or biological proteins. Evidence indicates 
Potential Health Concerns5
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that the degree of agglomeration can affect the 
toxicity of inhaled nano-objects [Shvedova et 
al. 2007].
Discrete nanoparticles are deposited in the 
lungs to a greater extent than larger respi-
rable particles [ICRP 1994], and deposi-
tion increases with exercise due to increase 
in breathing rate and change from nasal to 
mouth breathing [Jaques and Kim 2000; 
Daigle et al. 2003] and among persons with 
existing lung diseases or conditions (e.g., 
asthma, emphysema) [Brown et al. 2002]. 
Based on animal studies, discrete nano-
particles may enter the bloodstream from 
the lungs and translocate to other organs 
[Takenaka et al. 2001; Nemmar et al. 2002; 
Oberdörster et al. 2002].
Discrete nanoparticles (35–37-nm median 
diameter) that deposit in the nasal region 
may be able to enter the brain by translo-
cation along the olfactory nerve, as was 
observed in rats [Oberdörster et al. 2004; 
Oberdörster et al. 2005a; Elder et al. 2006]. 
The transport of insoluble particles from 
20–500 nm-diameter to the brain via senso-
ry nerves (including olfactory and trigemi-
nus) was reported in earlier studies in sever-
al animal models [De Lorenzo 1970; Adams 
and Bray 1983; Hunter and Dey 1998]. This 
exposure route for nanoparticles and to 
nanoscale biological agents has not been 
studied in humans. 
Some studies suggest that nanomaterials 
could potentially enter the body through 
the skin during occupational exposure. Tin-
kle et al. [2003] have shown that particles 
smaller than 1 µm in diameter may pene-
trate into mechanically flexed skin samples. 
A more recent study reported that nanopar-
ticles with varying physicochemical proper-
ties were able to penetrate the intact skin of 
pigs [Ryman-Rasmussen et al. 2006]. These 
nanoparticles were quantum dots of differ-
ent size, shape, and surface coatings. They 
were reported to penetrate the stratum core-
num barrier by passive diffusion and local-
ize within the epidermal and dermal layers 
within 8–24 hours. The dosing solutions 
were 2- to 4-fold dilutions of quantum dots 
as commercially supplied and thus represent 
occupationally relevant doses. 
At this time, it is not fully known whether skin 
penetration of nanoparticles would result in 
adverse effects in animal models. However, 
topical application of raw SWCNT to nude 
mice has been shown to cause dermal irrita-
tion [Murray et al. 2007]. Studies conducted 
in vitro using primary or cultured human 
skin cells have shown that both SWCNT and 
multi-walled carbon nanotubes (MWCNT) 
can enter cells and cause release of pro-in-
flammatory cytokines, oxidative stress, and 
decreased viability [Monteiro-Riviere et al. 
2005; Shvedova et al. 2003]. It remains un-
clear, however, how these findings may be 
extrapolated to a potential occupational 
risk, given that additional data are not yet 
available for comparing the cell model stud-
ies with actual conditions of occupational 
exposure. Research on the dermal exposure 
of nanomaterials is ongoing (www.uni-
leipzig.de/~nanoderm/). 
Ingestion can occur from unintentional 
hand to mouth transfer of materials; this 
has been found to happen with traditional 
materials, and it is scientifically reasonable 
to assume that it also could happen dur-
ing handling of nanomaterials. Ingestion 
may also accompany inhalation exposure 
because particles that are cleared from the 
respiratory tract via the mucociliary escala-
tor may be swallowed [ICRP 1994]. Little is 
known about possible adverse effects from 
the ingestion of nanomaterials.
5 Potential Health Concerns
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5.2 Effects Seen in Animal 
Studies 
Experimental studies in rats have shown 
that at equivalent mass doses, insoluble 
ultrafine particles are more potent than 
larger particles of similar composition in 
causing pulmonary inflammation, tissue 
damage, and lung tumors [Lee et al. 1985; 
Oberdörster and Yu 1990; Oberdörster et al. 
1992, 1994a,b; Heinrich et al. 1995; Driscoll 
1996; Lison et al. 1997; Tran et al. 1999, 2000; 
Brown et al. 2001; Duffin et al. 2002; Renwick 
et al. 2004; Barlow et al. 2005]. These studies 
have shown that for poorly-soluble low tox-
icity (PSLT) particles, the dose-response re-
lationships are consistent across particle siz-
es when dose is expressed as particle surface 
area. In addition to particle size and surface 
area, studies have shown that other particle 
characteristics can influence toxicity. For 
example, although the relationship between 
particle surface area dose and pulmonary 
inflammation is consistent among PSLT 
particles, crystalline silica is much more in-
flammogenic than PSLT particles at a given 
surface area dose [Duffin et al. 2007]. 
Reactive oxidant generation on the particle 
surface is an important factor influencing 
lung response to particles, which can be 
related to crystal structure. A recent study 
of the lung effects of rats dosed with either 
ultrafine anatase titanium dioxide (TiO
2)
 or 
ultrafine rutile TiO
2
 showed that the anatase 
TiO
2 
had more reactive surfaces and caused 
greater pulmonary inflammation and cell 
proliferation in the lungs of rats [Warheit 
et al. 2007]. In a cell-free assay designed to 
investigate the role of surface area and crys-
tal structure on particle reactive oxygen spe-
cies (ROS)-generation, Jiang et al. [2008] 
observed that size, surface area, and crystal 
structure all contribute to ROS generation. 
Figure 5–1. Formation of collagen following deposition of SWCNTs in the lungs of mice
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Oxidant generation was apparently associ-
ated with the number of defective sites per 
surface area, which varied in nanoparticles 
in some size ranges [Jiang et al. 2008]. 
These studies indicate that for nanoparticles 
with similar properties (e.g., PSLT), the tox-
icity of a given mass dose will increase with 
decreasing particle size due to the increasing 
surface area. However, the dose-response re-
lationship may differ for particles with differ-
ent chemical composition and other proper-
ties. Consistent with these findings, a recent 
pulmonary instillation study with rats dosed 
with either fine or ultrafine TiO
2
 reported 
no significant difference in lung responses 
when compared to controls, while crystal-
line silica caused more severe lung responses 
at the same dose [Warheit et al. 2006]. How-
ever, Warheit et al. [2006] were unable to ad-
equately test the hypotheses about the rela-
tionship between particle surface area dose 
and toxicity because the diameters of the fine 
and ultrafine TiO
2
-instilled particles did not 
significantly differ due to particle agglomera-
tion, both being in excess of 2 µm. When ef-
forts were made to more effectively disperse 
fine and ultrafine particles, the effect of sur-
face area on the pulmonary response in rats 
after intratracheal instillation was verified 
[Sager et al. 2008]. 
5.2.1 Polytetrafluoroethylene fume
Among ultrafine particles, freshly generated 
polytetrafluoroethylene (PTFE) fume (gen-
erated at temperatures of more than 425oC) is 
known to be highly toxic to the lungs. Freshly 
generated PTFE fume caused hemorrhagic 
pulmonary edema and death in rats exposed 
to less than 60 µg/m3 [Oberdörster et al. 
1995]. In contrast, aged PTFE fume was much 
less toxic and did not result in mortality. This 
low toxicity was attributed to the increase 
in particle size from accumulation and to 
changes in surface chemistry [Johnston et al. 
2000; Oberdörster et al. 2005a]. Human case 
studies have reported pulmonary edema in 
workers exposed to PTFE fume and an acci-
dental death in a worker when an equipment 
malfunction caused overheating of the PTFE 
resin and release of the PTFE pyrolysis prod-
ucts in the workplace [Goldstein et al. 1987; 
Lee et al. 1997]. While PTFE fume differs 
from engineered nanoparticles, these studies 
illustrate properties of ultrafine particles that 
have been associated with an acute toxic haz-
ard. Enclosed processes and other engineer-
ing controls appear to have been effective at 
eliminating worker exposures to PTFE fume 
in normal operations, and thus may provide 
examples of control systems that may be im-
plemented to prevent exposure to nanopar-
ticles that may have similar  properties.
5.2.2 Carbon nanotubes 
Carbon nanotubes (CNT) are specialized 
forms or structures of engineered nanomate-
rials that have had increasing production and 
use [Donaldson et al. 2006]. Consequently, a 
number of toxicologic studies of CNT have 
been performed in recent years. These stud-
ies have shown that the toxicity of CNT may 
differ from that of other nanomaterials of 
similar chemical composition. For example, 
single-walled CNTs (SWCNT) have been 
shown to produce adverse effects including 
granulomas in the lungs of mice and rats at 
mass doses at which ultrafine carbon black 
did not produce these adverse effects [Shve-
dova et al. 2005; Lam et al. 2004]. While both 
SWCNTs and carbon black are carbon-based, 
SWCNTs have a unique, convoluted, fibrous 
structure and specific surface chemistry that 
offers excellent electrical conductive proper-
ties. How these characteristics may influence 
5 Potential Health Concerns
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toxicity is not known. Carbon nanotubes may 
contain metal catalysts as byproducts of their 
production, which could contribute to their 
toxicity, or the CNTs may provide a structure 
that promotes fibroblast cell growth [Wang 
et al. 2008].
In a study of SWCNTs instilled into the lungs 
of rats, multi-focal granulomas (without tran-
sient inflammation or persistent lesions) were 
observed at doses of 1 or 5  mg / kg body weight 
[Warheit et al. 2004]. In a study of mice in-
stilled with one of several types of SWCNTs 
(i.e., raw, purified, iron-containing, and nick-
el-containing) at doses of 0.1 or 0.5 mg/mouse 
(approximately 3 or 16 mg/kg body weight), 
dose-dependent epithelioid granulomas were 
observed at 7 days, which persisted at 90 days 
[Lam et al. 2004, 2006]. Both the raw and pu-
rified forms produced interstitial inflamma-
tion, while mortality (5/9 mice) was observed 
in the high dose group of the Ni-containing 
SWCNT. 
NIOSH researchers recently reported adverse 
lung effects following pharyngeal aspiration 
of SWCNTs in mice using doses between 
10–40 µg/mouse (approximately 0.5–2  mg / kg 
body weight) [Shvedova et al. 2005]. The find-
ings showed that exposure to SWCNTs in mice 
lead to transient pulmonary inflammation, 
oxidative stress, decrease in pulmonary func-
tion, decrease in bacterial clearance, and early 
onset of interstitial fibrosis. Deposition of ag-
glomerates resulted in development of granu-
lomas, while deposition of dispersed nanotube 
structures in the aspirated suspension resulted 
in the rapid development of interstitial fibro-
sis (within 7 days), which progressed over a 
30–60 day post-exposure period [Shvedova 
et al. 2005; Mercer et al. 2008]. Evidence in-
dicates that when efforts were made to more 
fully disperse the SWCNT and obtain smaller 
structures in the aspiration suspension, fewer 
granulomas occurred but a 4-fold more po-
tent interstitial fibrotic response was observed 
[Mercer et al. 2008]. 
Exposure to SWCNT has been observed to be 
more fibrogenic than an equal mass of either 
ultrafine carbon black or fine quartz [Shve-
dova et al. 2005; Lam et al. 2004]. Based on 
their findings in mice, Shvedova et al. [2005] 
estimated that workers may be at risk of devel-
oping lung lesions if they were exposed to SW-
CNT over a period of 20 days at the current 
Figure 5–2. Deposition and clearance of MWCNTs from the conducting airways of mice 
following inhalation exposure
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OSHA PEL for graphite (5 mg/m3). Lam et al. 
[2004, 2006] provided similar estimates and 
suggested that the graphite PEL should not 
be used (e.g., on MSDS) as a safe concentra-
tion for workers exposed to CNTs. Compared 
to instillation, the pharyngeal aspiration tech-
nique may approximate more closely the par-
ticle deposition that occurs during inhalation. 
Inhalation studies of CNTs may provide more 
definitive information about their potential 
toxicity in humans [Donaldson et al. 2006]. 
Recently, NIOSH scientists designed a system 
to generate an aerosol of SWCNT for a rat in-
halation study [Baron et al. 2008]. Results of 
the inhalation exposure to SWCNT [Shvedova 
et al. 2008] were qualitatively similar to those 
of the aspiration study [Shvedova et al. 2004] 
with a 4-fold more potent interstitial fibrotic 
response similar to that reported by Mercer 
et al. [2008]. Another NIOSH study found 
markers of inflammation in the lung, aorta, 
and heart tissues of ApoE-/- mice after a single 
intra-pharyngeal instillation dose of SWCNT 
(10 and 40 µg/mouse) and accelerated plaque 
formation after repeated doses (20 µg/mouse 
once every other week for 8 weeks in mice fed 
an atherogenic diet) [Li et al. 2007].
MWCNTs were recently studied by intratra-
cheal instillation in Sprague-Dawley rats re-
ceiving 0.5, 2, or 5 mg (approximately 2, 9, 
or 22 mg/kg body weight) of either ground 
MWCNT or unground MWCNT [Muller et 
al. 2005]. Both forms produced pulmonary 
inflammation and fibrosis. Rats that received 
ground MWCNT showed greater dispersion 
in the lungs, and fibrotic lesions were ob-
served in the deep lungs (alveolar region). In 
rats treated with MWCNT (not ground) fi-
brosis showed mainly in their airways rather 
than in their lungs. The biopersistence of the 
unground MWCNT was greater than that of 
the ground MWCNT, with 81% vs. 36%, re-
spectively, remaining in the lungs at day 60. 
At an equal mass dose, ground MWCNT pro-
duced a similar inflammatory and fibrogenic 
response as chrysotile asbestos and a greater 
response than ultrafine carbon black [Muller 
et al. 2005]. Effects from the vehicle (1% 
Tween 80) used for administering ground 
and unground MWCNT to rats were not re-
ported; the control group used in the study 
was exposed to only saline. NIOSH scientists 
have exposed mice by aspiration to MWCNT 
suspended in a simulated alveolar lining fluid 
rather than Tween 80. Control studies show 
that this suspension medium was not inflam-
matory and did not mask the biological activ-
ity of the particle surface. Data indicate that 
aspiration of dispersed MWCNT produced 
pulmonary inflammation, which peaked 
7 days post exposure. The inflammatory re-
sponse to MWCNT was greater than the in-
flammatory response to SWCNT [Sriram et 
al. 2007]. 
Two recent studies investigated the hypothe-
ses that CNTs can behave like asbestos. In the 
first study, Takagi et al. [2008] administered 
to p53 (+/-) mice MWCNT, fullerene, or cro-
cidolite asbestos by intraperitoneal injection 
at doses of 3 mg/mouse. The average width 
of the MWCNT was approximately 100 nm, 
and approximately 28% of the particles were 
longer than 5 µm. The particle number con-
centrations of MWCNT and crocidolite were 
1 × 109 and 1 × 1010 (in 1-ml suspensions), 
respectively, although the MWCNT sample 
was also reported to contain mainly large ag-
gregates, indicating that the number of MW-
CNT fibers was vastly underestimated and 
much larger than for the asbestos exposure. 
At the termination of the study (25 weeks), 
mesothelial responses in the MWCNT-
treated mice included moderate to severe 
fibrous peritoneal adhesion and peritoneal 
tumors. The asbestos-treated mice had simi-
lar responses but to a lesser extent, while the 
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fullerene-treated group did not show these 
responses. Mesothelioma was considered by 
the authors as the primary cause of death, 
and constriction of the ileus due to severe 
peritoneal adhesion was considered to be the 
second major cause of death, suggesting that 
3 mg/mouse exceeded the maximum toler-
ated dose of MWCNT. Whether mesothelio-
mia was a primary cause of death is some-
what speculative. 
In a second study, Poland et al. [2008] admin-
istered to mice either MWCNT (two short 
and two long CNT samples), nanoscale car-
bon black, or amosite (short or long) at dos-
es of 50 µg/mouse by intraperitoneal injec-
tion. The short CNTs were 10 nm or 15 nm 
in width, with no fibers larger than 15 µm in 
length detected; the long CNTs were 85 nm 
or 165 nm in width, and 24% or 84%, re-
spectively, were larger than 15 µm in length 
(the percentage of fibers longer than 5 µm 
was not reported). After either 24 hours or 
7 days, the long MWCNT caused inflamma-
tion and granulomatous lesions that were 
qualitatively and quantitatively similar to 
that caused by the long asbestos. The short, 
low-aspect-ratio, tangled aggregates of MW-
CNT did not produce these responses at the 
doses used in this study. Additional studies 
are needed to determine if this inflammato-
ry response to MWCNT would be persistent 
and result in tumors of the abdominal wall. 
Additionally, the potential for migration of 
MWCNT through the lungs to the mesothe-
lium after inhalation requires investigation. 
Long-term studies are also needed to deter-
mine whether CNTs can cause cancer such 
as mesothelioma in laboratory animals, in-
cluding exposures by typical routes in hu-
mans (i.e., inhalation, dermal penetration, 
and ingestion) and at doses that include 
those equivalent to potential workplace ex-
posures. 
These studies indicate the need for more 
data on exposures of workers to CNTs. 
Maynard et al. [2004] reported relatively 
low short-term (approximately 30 min) 
airborne mass concentrations of SWCNT 
(0.007–0.053 mg/m3) in a laboratory pro-
duction facility. A recent study by Han et al. 
[2008] reported total airborne mass concen-
trations of MWCNT from 0.21–0.43 mg/m3 
(4–6-hr sampling) in a laboratory research 
facility prior to use of engineering control 
measures; after implementing controls, the 
concentration decreased to nondetectable. 
Workers could also be exposed to ground 
CNTs used in polymer composites and 
other matrices or during cutting, grinding, 
or polishing of these materials. Given that 
exposure to SWCNT and MWCNT causes 
interstitial fibrosis and pulmonary inflam-
mation, respectively, in rodent lungs at rela-
tively low mass doses, it is prudent to mini-
mize worker exposure to airborne CNTs 
(see Chapter 8 Guidelines for Working with 
Engineered Nanomaterials). 
5.3 Observations from 
Epidemiological Studies 
Involving Fine and Ultrafine 
Particles 
Epidemiological studies in workers exposed 
to aerosols including fine and ultrafine parti-
cles have reported lung function decrements, 
adverse respiratory symptoms, chronic ob-
structive pulmonary disease, and fibrosis 
[Kreiss et al. 1997; Gardiner et al. 2001; An-
tonini 2003]. In addition, some studies have 
found lung disease including elevated lung 
cancer and neurological effects among work-
ers exposed to certain ultrafine particles (i.e., 
diesel exhaust particulate) [Steenland et al. 
1998; Garshick et al. 2004, 2006; Hart et al. 
2006] or welding fumes [Antonini 2003; Park 
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et al. 2006; Ambroise et al. 2007; Bowler et al. 
2007]. The implications of these studies to 
engineered nanomaterials, which may have 
different particle properties, are uncertain. 
Studies of airborne particles and fibers in the 
workplace do provide relevant background 
information about the particle-related lung 
diseases and mechanisms, and some limited 
quantitative estimates of exposures and risk 
of adverse health effects. As such, these stud-
ies provide a point of reference, including 
baseline information and estimates regard-
ing possible health risks of exposure to other 
nanoscale particles depending on the extent 
to which the exposure conditions and parti-
cle-biological interactions may be similar. 
Epidemiological studies in the general popu-
lation have also shown associations between 
particulate air pollution and increased mor-
bidity and mortality from respiratory and 
cardiovascular diseases [Dockery et al. 1993; 
HEI 2000; Pope et al. 2002, 2004]. Some 
epidemiological studies have shown adverse 
health effects associated with exposure to 
the ultrafine particulate fraction of air pol-
lution [Peters et al. 1997, 2004; Penttinen et 
al. 2001; Ibald-Mulli et al. 2002; Timonen 
et al. 2004; Ruckerl et al. 2006] although 
uncertainty exists about the role of ultra-
fine particles relative to other air pollutants 
in causing the observed adverse health ef-
fects. The associations in these studies have 
been based on measurements of the particle 
number or mass concentrations of particles 
within certain size fractions (e.g., particulate 
matter with diameter of 2.5 µm and smaller 
[PM
2.5
]). In an experimental study of healthy 
and asthmatic subjects inhaling ultrafine 
carbon particles, changes were observed in 
the expression of adhesion molecules by 
blood leukocyte, which may relate to pos-
sible cardiovascular effects of ultrafine par-
ticle exposure [Frampton et al. 2006]. Short-
term diesel exhaust exposure (0.3 mg/ m3 for 
1 hr) in healthy volunteers was associated 
with mild systemic inflammation and im-
paired  endothelial-dependent vasodilation 
[Törnqvist et al. 2007].
5.4 Hypotheses from Animal 
and Epidemiological 
Studies
The existing literature on particles and fi-
bers provides a scientific basis from which to 
evaluate the potential hazards of engineered 
nanomaterials. While the properties of en-
gineered nanomaterials can vary widely, 
the basic physicochemical and toxicokinetic 
principles learned from the existing studies 
are relevant to understanding the poten-
tial toxicity of nanomaterials. For example, 
it is known from studies in humans that a 
greater proportion of inhaled nanoparticles 
will deposit in the respiratory tract (both at 
rest and with exercise) compared to larger 
particles [ICRP 1994; Jaques and Kim 2000; 
Daigle et al. 2003; Kim and Jaques 2004]. It 
is also known from studies in animals that 
nanoparticles in the lungs can be trans-
located to other organs in the body; how 
the chemical and physical properties of the 
nanoparticles influence this translocation 
is not completely known [Takenaka et al. 
2001; Kreyling et al. 2002; Oberdörster et al. 
2002, 2004; Semmler et al. 2004; Geiser et al. 
2005]. Due to their small size, nanoparticles 
can cross cell membranes and interact with 
subcellular structures such as mitochondria, 
where they have been shown to cause oxida-
tive damage and to impair function of cells 
in culture [Möller et al. 2002, 2005; Li et al. 
2003; Geiser et al. 2005]. Nanoparticles have 
also been observed inside cell nuclei [Porter 
et al. 2007a, b]. Animal studies have shown 
that nanoparticles are more biologically 
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active due to their greater surface area per 
mass compared with larger-sized particles 
of the same chemistry [Oberdörster et al. 
1992; 1994a,b; 2005a; Driscoll 1996; Lison 
et al. 1997; Brown et al. 2001; Duffin et al. 
2002; Renwick et al. 2004; Barlow et al. 2005; 
Sager et al. 2008]. While this increased bio-
logical activity is a fundamental component 
to the utility of nanoparticles for industrial, 
commercial, and medical applications, the 
consequences of unintentional exposures of 
workers to nanoparticles are uncertain. 
Research reported from laboratory animal 
studies and from epidemiological studies 
have lead to hypotheses regarding the po-
tential adverse health effects of engineered 
nanomaterials. These hypotheses are based 
on the scientific literature of particle expo-
sures in animals and humans. This litera-
ture has been recently reviewed [Donaldson 
et al. 2005; Maynard and Kuempel 2005; 
Oberdörster et al. 2005a, Donaldson et al. 
2006; Kreyling et al. 2006]. In general, the 
particles used in past studies have not been 
characterized to the extent recommended 
for new studies in order to more fully under-
stand the physicochemical properties of the 
particles that influence toxicity [Oberdörst-
er et al. 2005b; Thomas et al. 2006]. As this 
research continues, more data will become 
available to support or refute the following 
hypotheses for engineered nanoparticles. 
Hypothesis 1: Exposure to engineered nano-
particles is likely to cause adverse health ef-
fects similar to ultrafine particles that have 
similar physical and chemical characteris-
tics.
Studies in rodents and humans support the 
hypothesis that exposure to ultrafine particles 
poses a greater respiratory hazard than expo-
sure to the same mass of larger particles with 
a similar chemical composition. Studies of 
existing particles have shown adverse health 
effects in workers exposed to ultrafine par-
ticles (e.g., diesel exhaust particulate, welding 
fumes), and animal studies have shown that 
ultrafine particles are more inflammogenic 
and tumorigenic in the lungs of rats than an 
equal mass of larger particles of similar com-
position [Oberdörster and Yu 1990; Driscoll 
1996; Tran et al. 1999, 2000]. If engineered 
nanoparticles have the same physicochemi-
cal characteristics that are associated with 
reported effects from ultrafine particles, 
they may pose the same health concerns. 
Although the physicochemical characteristics 
of ultrafine particles and engineered nanopar-
ticles can differ, the toxicologic and dosimetric 
principles derived from available studies may 
be relevant to postulating the health concerns 
for newly engineered particles. The biological 
mechanisms of particle-related lung diseases 
(i.e., oxidative stress, inflammation, and pro-
duction of cytokines, chemokines, and cell 
growth factors) [Mossman and Churg 1998; 
Castranova 2000; Donaldson and Tran 2002] 
appear to be a consistent lung response for re-
spirable particles including ultrafine or engi-
neered nanoparticles [Donaldson et al. 1998; 
Donaldson and Stone 2003; Oberdörster et al. 
2005a]. Toxicological studies have shown that 
the chemical and physical properties that in-
fluence the fate and toxicity of ultrafine par-
ticles may also be relevant to mechanisms in-
fluencing biological exposure and response to 
other nanoscale particles [Duffin et al. 2002; 
Kreyling et al. 2002; Oberdörster et al. 2002; 
Semmler et al. 2004; Nel et al. 2006]. 
Hypothesis 2: Surface area and activity and 
particle number may be better predictors of 
potential hazard than mass.
The greater potential hazard may relate to the 
greater number or surface area of nanopar-
ticles compared with that for the same mass 
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concentration of larger particles [Oberdörst-
er et al. 1992, 1994a,b; Driscoll et al. 1996; 
Tran et al. 2000; Brown et al. 2001; Peters et 
al. 1997; Moshammer and Neuberger 2003; 
Sager et al. 2008]. This hypothesis is based 
primarily on the pulmonary effects observed 
in studies of rodents exposed to various types 
of ultrafine or fine particles (i.e., TiO
2
, car-
bon black, barium sulfate, carbon black, die-
sel soot, coal fly ash, toner) and in humans 
exposed to aerosols, including nanoscale 
particles (e.g., diesel exhaust, welding fumes). 
These studies indicate that for a given mass 
of particles, relatively insoluble nanoparticles 
are more toxic than larger particles of simi-
lar chemical composition and surface prop-
erties. Studies of fine and ultrafine particles 
have shown that particles with less reactive 
surfaces are less toxic [Tran et al. 1999; Duf-
fin et al. 2002]. However, even particles with 
low inherent toxicity (e.g., TiO
2
) have been 
shown to cause pulmonary inflammation, 
tissue damage, and fibrosis at sufficiently 
high particle surface area doses [Oberdörster 
et al. 1992, 1994a,b; Tran et al. 1999, 2000].
Through engineering, the properties of nano-
materials can be modified. For example, a re-
cent study has shown that the cytotoxicity of 
water-soluble fullerenes can be reduced by 
several orders of magnitude by modifying 
the structure of the fullerene molecules (e.g., 
by hydroxylation) [Sayes et al. 2004]. These 
structural modifications were shown to re-
duce the cytotoxicity by reducing the genera-
tion of oxygen radicals—which is a probable 
mechanism by which cell membrane damage 
and death occurred in these cell cultures. In-
creasing the sidewall functionalization of SW-
CNT also rendered these nanomaterials less 
cytotoxic to cells in culture [Sayes et al. 2005]. 
Cytotoxicity studies with quantum dots have 
shown that the type of surface coating can have 
a significant effect on cell motility and viabil-
ity [Hoshino et al. 2004; Shiohara et al. 2004; 
Lovric et al. 2005]. Differences in the phase 
composition of nanocrystalline structures 
can influence their cytotoxicity; in a recent 
study comparing two types of TiO
2
 nanopar-
ticles exposed to UV radiation, anatase TiO
2
 
was more cytotoxic and produced more reac-
tive species than did rutile TiO
2
 with similar 
specific surface area (153 m2g and 123 m2g of 
TiO
2
, respectively) [Sayes et al. 2006]. Reactive 
oxygen species were also associated with the 
cytotoxicity of TiO
2 
nanoparticles to mouse 
microglia (brain cells) grown in culture [Long 
et al. 2006]. In contrast, in vitro generation 
of oxidant species is relatively low in purified 
SWCNT (contaminating metals removed), 
yet this material caused progressive interstitial 
fibrosis in vivo [Shvedova et al. 2004; 2005]. 
However, recent in vitro studies indicate that 
purified SWCNTs enhance proliferation and 
collagen production in fibroblasts [Wang et al. 
2008]. Therefore, oxidant generation may not 
be the only mechanism driving the biological 
activity of nanomaterials. 
The studies of ultrafine particles may pro-
vide useful data to develop preliminary 
hazard or risk assessments and to generate 
hypotheses for further testing. The studies 
in cell cultures provide information about 
the cytotoxic properties of nanomaterials 
that can guide further research and toxicity 
testing in whole organisms. More research 
is needed of the specific particle properties 
and other factors that influence the toxicity 
and disease development, including those 
characteristics that may be most predictive 
of the potential safety or toxicity of newly 
engineered nanomaterials.
5 Potential Health Concerns
Approaches to Safe Nanotechnology 21
Very little is known about the safety risks 
that engineered nanomaterials might pose, 
beyond some data indicating that they pos-
sess certain properties associated with safety 
hazards in traditional materials. Based upon 
currently available information, the poten-
tial safety concerns most likely would in-
volve catalytic effects or fire and explosion 
hazards if nanomaterials are found to be-
have similarly to traditional materials. 
6.1 Fire and Explosion Risk
Although insufficient information exists to 
predict the fire and explosion risk associated 
with nanoscale powders, nanoscale combus-
tible material could present a higher risk 
than a similar quantity of coarser mate-
rial, given its unique properties [HSE 2004]. 
Decreasing the particle size of combustible 
materials can increase combustion potential 
and combustion rate, leading to the possi-
bility of relatively inert materials becoming 
highly reactive in the nanometer size range. 
Dispersions of combustible nanomaterial in 
air may present a greater safety risk than dis-
persions of non- nanomaterials with similar 
compositions. Some nanomaterials are de-
signed to generate heat through the progres-
sion of reactions at the nanoscale. Such mate-
rials may present a fire hazard that is unique 
to engineered nanomaterials. In the case of 
some metals, explosion risk can increase sig-
nificantly as particle size decreases.
The greater activity of nanoscale materials 
forms a basis for research into nanoenerget-
ics. For instance, nanoscale Al/MoO
3
 ther-
mites ignite more than 300 times faster than 
corresponding micrometer-scale material 
[Granier and Pantoya 2004].
6.2 Risks of Catalytic 
Reactions
Nanoscale particles and nanostructured po-
rous materials have been used as effective 
catalysts for increasing the rate of reactions 
or decreasing the necessary temperature 
for reactions to occur in liquids and gas-
es. Depending on their composition and 
structure, some nanomaterials may initi-
ate catalytic reactions that, based on their 
chemical composition, would not other-
wise be anticipated [Pritchard 2004]. 
Potential Safety Hazards6
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There are currently no national or interna-
tional consensus standards on measurement 
techniques for nanomaterials in the work-
place. If the qualitative assessment of a pro-
cess has identified potential exposure points 
and leads to the decision to measure nano-
materials, several factors must be kept in 
mind. Current research indicates that mass 
and bulk chemistry may be less important 
than particle size, surface area, and surface 
chemistry (or activity) for nanostructured 
materials [Oberdörster et al. 1992, 1994a,b; 
Duffin et al. 2002]. Research is ongoing into 
the relative importance of these different 
exposure metrics, and how to best charac-
terize exposures to nanomaterials in the 
workplace. In addition, the unique shape 
and properties of some nanomaterials may 
pose additional challenges. For example, the 
techniques used to measure fiber concentra-
tions in the workplace (e.g., phase contrast 
microscopy) would not be able to detect in-
dividual carbon nanotubes with diameters 
less than 100 nm nor bundles of carbon 
nanotubes with diameters less than 250 nm 
[Donaldson et al. 2006]. NIOSH and the 
National Institute of Standards and Tech-
nology (NIST) are collaborating on efforts 
to develop nanoscale reference materials for 
exposure assessment. Initial effort is focused 
on development of TiO
2 
reference material. 
7.1 Workplace Exposures
While research continues to address ques-
tions of nanomaterial toxicity, a number 
of exposure assessment approaches can be 
used to help determine worker exposures to 
airborne nanomaterials. These assessments 
can be performed using traditional indus-
trial hygiene sampling methods including 
samplers placed at static locations (area 
sampling), samples collected in the breath-
ing zone of the worker (personal sampling), 
or real-time devices or methods that can be 
personal or static. In general, personal sam-
pling is preferred to ensure an accurate repre-
sentation of the worker’s exposure, whereas 
area samples (e.g., size-fractionated aerosol 
samples) and real-time (direct-reading) ex-
posure measurements may be more useful 
for evaluating the need for improvement of 
engineering controls and work practices. 
Many of the sampling techniques that are 
available for measuring nanoaerosols vary 
in complexity but can provide useful in-
formation for evaluating occupational ex-
posures with respect to particle size, mass, 
surface area, number concentration, com-
position, and surface chemistry. Unfortu-
nately, relatively few of these techniques are 
readily applicable to routine exposure mon-
itoring. Research is ongoing into developing 
an analytical strategy for determining both 
TiO
2 
surface area and titanium mass from 
37-mm cassette filter samplers. Current 
measurement techniques are described be-
low along with their applicability for moni-
toring nanometer aerosols.
For each measurement technique used, it 
is vital that the key parameters associated 
with the technique and sampling method-
ology be recorded when measuring expo-
sure to nanoaerosols. This should include 
the response range of the instrumentation, 
Exposure Assessment and Characterization7
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whether personal or static measurements 
are made, and the location of all poten-
tial aerosol sources including background 
aerosols. Comprehensive documentation 
will facilitate comparison of exposure mea-
surements using different instruments or 
different exposure metrics and will aid the 
re- interpretation of historic data as fur-
ther information is developed on health-
appropriate exposure metrics. Regardless 
of the metric and method selected for ex-
posure monitoring, it is critical that mea-
surements be taken before production or 
processing of a nanomaterial to obtain 
background nanoparticle exposure data. 
Measurements made during production or 
processing can then be evaluated to deter-
mine if there has been an increase in particle 
number concentrations in relation to back-
ground measurements and whether that 
change represents worker exposure to the 
nanomaterial. Table 7–1 gives a listing of in-
struments and measurement methods that 
can be used in the evaluation of engineered 
nanoparticle exposures.
Figure 7–1. Examples of different sampling instruments used to measure occupational 
exposures to nanoparticles including the determination of real-time particle number 
concentrations and size-fractionated mass concentrations
7.1.1 Size-fractionated aerosol 
sampling 
Studies indicate that particle size plays an 
important role in determining the potential 
adverse effects of nanomaterials in the respi-
ratory system: by influencing the physical, 
chemical, and biological nature of the mate-
rial; by affecting the surface-area dose of de-
posited particles; and by enabling deposited 
particles to more readily translocate to other 
parts of the body. Animal studies indicate 
that the toxicity of inhaled nanoparticles 
is more closely associated with the particle 
surface area and particle number than with 
the particle mass concentration when com-
paring aerosols with different particle size 
distributions. However, mass concentration 
measurements may be applicable for evalu-
ating occupational exposure to nanometer 
aerosols where a good correlation between 
the surface area of the aerosol and mass 
concentration can be determined or if tox-
icity data based on mass dose are available 
for a specific nanoscale particle associated 
7 Exposure Assessment and Characterization
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with a known process (e.g., diesel exhaust 
particulate). 
Aerosol samples can be collected using in-
halable, thoracic, or respirable samplers, 
depending on the region of the respiratory 
system most susceptible to the inhaled par-
ticles. Since prevailing information suggests 
that a large fraction of inhaled nanopar-
ticles will deposit in the gas-exchange re-
gion of the lungs [ICRP 1994], respirable 
samplers would be appropriate. Respirable 
samplers will also collect a nominal amount 
of nanoscale particles that can deposit in the 
upper airways and ultimately be cleared or 
transported to other parts of the body. 
Table 7–1. Summary of instruments and measurement methods used in the evaluation 
of nanomaterial exposures*
Metric  Instrument or method Remarks
Mass-Direct (total and/
or elemental) 
Size Selective Static 
Sampler
The only instruments offering a cut point around 
100 nm are cascade impactors (Berner-type low 
pressure impactors, or Micro orifice impactors). 
Allows gravimetric and chemical analysis of 
samples on stages below 100 nm.
TEOM® 
(Tapered Element 
Oscillating 
Microbalance)
Sensitive real-time monitors such as the TEOM 
may be useable to measure nanoaerosol mass 
concentration on-line with a suitable size 
selective inlet.
Filter collection and 
elemental analysis
Filters may be collected with size selective pre-
samplers or open face. Elemental analysis (e.g., 
carbon, metals) for mass determination.
Mass-Indirect 
(calculation)
ELPITM 
(Electrical Low Pressure 
Impactor)
Real time size-selective (aerodynamic diameter) 
detection of active surface area concentration 
giving aerosol size distribution. Mass 
concentration of aerosols can be calculated when 
particle charge and density are known or assumed.
MOUDI 
(Micro-Orfice Uniform 
Deposit Impactor)
Real time size-selective (aerodynamic diameter) 
by cascade impaction.
DMAS 
(Differential Mobility 
Analyzing System)
Real time size-selective (mobility diameter) 
detection of number concentration, giving 
aerosol size distribution. Mass concentration of 
aerosols can be calculated when particle shape 
and density are known or assumed.
(continued)
See footnotes at end of table.
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Table 7–1 (Continued). Summary of instruments and measurement methods used in 
the evaluation of nanomaterial exposures*
Metric  Instrument or method Remarks
Number-Direct CPC 
 (Condensation Particle 
Counter)
CPCs provide real time number concentration 
measurements between their particle diameter 
detection limits. Without a nanoparticle pre-
separator they are not specific to the nanometer 
size range. Some models have diffusion screen 
to limit top size to 1 µm.
OPC 
(Optical Particle 
Counter)
OPCs provide real time number concentration 
measurements between their particle diameter 
detection limits. Particle size diameters begin at 
300 nm and may go up to 10,000 nm.
DMAS and SMPS 
(Scanning Mobility 
Particle Sizer)
Real time size-selective (mobility diameter) 
detection of number concentration giving 
number-based size distribution.
 Electron Microscopy Off-line analysis of electron microscope samples 
can provide information on size-specific aerosol 
number concentration.
Number-Indirect ELPITM and MOUDI Real time size-selective (aerodynamic diameter) 
detection of active surface-area concentration 
giving aerosol size distribution. Data may be 
interpreted in terms of number concentration. 
Size-selective samples may be further analyzed 
off-line.
Surface Area-Direct Diffusion Charger Real-time measurement of aerosol active surface-
area. Active surface-area does not scale directly 
with geometric surface-area above 100 nm. Note 
that not all commercially available diffusion 
chargers have a response that scales with particle 
active surface-area below 100 nm. Diffusion 
chargers are only specific to nanoparticles if used 
with appropriate inlet pre-separator.
ELPITM  and MOUDI Real-time size-selective (aerodynamic diameter) 
detection of active surface-area concentration. 
Active surface-area does not scale directly with 
geometric surface-area above 100 nm.
(continued)
See footnotes at end of table.
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Table 7–1 (Continued). Summary of instruments and measurement methods used in 
the evaluation of nanomaterial exposures*
Metric  Instrument or method Remarks
Surface Area-Direct 
(continued)
 Electron Microscopy Off-line analysis of electron microscope samples 
(previously collected on filters or other media) 
can provide information on particle surface-area 
with respect to size. TEM analysis provides direct 
information on the projected area of collected 
particles which may be related to geometric area 
for some particles shapes.
Surface Area-Indirect 
(calculation)
DMAS and SMPS Real time size-selective (mobility diameter) 
detection of number concentration. Data may be 
interpreted in terms of aerosol surface-area under 
certain circumstances. For instance, the mobility 
diameter of open agglomerates has been shown to 
correlate with projected surface area.
DMAS and ELPITM used 
in parallel
Differences in measured aerodynamic and 
mobility can be used to infer particle fractal 
dimension which can be further used to 
estimate surface-area. 
*Adapted from ISO/TR 12885
Note: Inherent to all air sampling instruments in this table is the fact that they cannot discriminate the 
nanoaerosol of interest from other airborne particles. Also, there is a general lack of validation regarding 
the response of these air sampling instruments to the full spectrum of nanoparticles that may be found in 
the workplace, including varieties of primary particles, agglomerates or aggregates, and other physical and 
chemical forms. A suite of nanoparticle reference materials are required to perform the needed validations. 
Respirable samplers allow mass-based ex-
posure measurements to be made using gra-
vimetric and/or chemical analysis [NIOSH 
1994]. However, they do not provide informa-
tion on aerosol number, size, or surface-area 
concentration, unless the relationship between 
different exposure metrics for the aerosol (e.g., 
density, particle shape) has been previously 
characterized. Currently, no commercially 
available personal samplers are designed to 
measure the particle number, surface area, or 
mass concentration of nanoaerosols. However, 
several methods are available that can be used 
to estimate surface area, number, or mass con-
centration for particles smaller than 100 nm. 
The use of conventional impactor samplers 
to assess nanoparticle exposure is limited 
since the impaction collection efficiencies 
are 200–300 nm. Low-pressure cascade im-
pactors that can measure particles to 50 nm 
and larger may be used for static sampling 
since their size and complexity preclude their 
use as personal samplers [Marple et al. 2001; 
Hinds 1999]. A personal cascade impactor 
is available with a lower aerosol cut point of 
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250 nm [Misra et al. 2002], allowing an ap-
proximation of nanoscale particle mass con-
centration in the worker’s breathing zone. 
For each method, the detection limits are on 
the order of a few micrograms of material on 
a filter or collection substrate [Vaughan et al. 
1989]. Cascade impactor exposure data gath-
ered from worksites where nanomaterials are 
being processed or handled can be used to 
make assessments as to the efficacy of expo-
sure control measures. 
7.1.2 Real-time aerosol sampling 
The real-time (direct-reading) measure-
ment of nanometer aerosol concentra-
tions is limited by the sensitivity of the 
instrument to detect small particles. Many 
real-time aerosol mass monitors used in 
the workplace rely on light scattering from 
groups of particles (photometers). This 
methodology is generally insensitive to par-
ticles smaller than 100 nm [Hinds 1999]. 
Optical instruments that size individual 
particles and convert the measured distri-
bution to a mass concentration are simi-
larly limited to particles larger than 100 nm. 
Quantitative information gained by optical 
particle counters may also be limited by rel-
atively poor counting efficiencies at smaller 
particle diameters (i.e., less than 500 nm). 
These instruments are capable of operating 
within certain concentration ranges that, 
when exceeded, affect the count or mass 
determination efficiencies due to coinci-
dence errors at the detector. Similarly, the 
response of optical particle counters may 
be material-dependent according to the re-
fractive index of the particle. The Scanning 
Mobility Particle Sizer (SMPS) is widely 
used as a research tool for characterizing 
nanoscale aerosols although its applicabil-
ity for use in the workplace may be limited 
because of its size, cost, and the inclusion of 
a radioactive source. Additionally, the SMPS 
may take 2–3 minutes to scan an entire size 
distribution; thus, it may be of limited use 
in workplaces with highly variable aero-
sol size distributions, such as those close 
to a strong particle source. Fast (less than 1 
second), mobility-based, particle-sizing in-
struments are now available commercially; 
however, having fewer channels, they lack 
the finer sizing resolution of the SMPS. The 
Electrical Low Pressure Impactor (ELPI) 
is an alternative instrument that combines 
diffusion charging and a cascade impactor 
with real-time (less than 1 second) aerosol 
charge measurements providing aerosol size 
distributions by aerodynamic diameter [Ke-
skinen et al. 1992]. 
7.1.3 Surface-area measurements
Relatively few techniques exist to monitor 
exposures with respect to aerosol surface 
area. Particle surface is composed of inter-
nal surface area attributable to pores (cavities 
more deep than wide), external surface area 
due to roughness (cavities more wide than 
deep), and total surface area (the accessible 
area of all real particle surfaces). A standard 
gas adsorption technique (i.e., BET) is used 
to measure the total surface area of powders 
and can be adapted to measure the specific 
surface area (surface area per unit mass) of 
engineered nanomaterials [Brunauer et al. 
1938]. However, surface-area analysis by gas 
adsorption requires relatively large quantities 
of material, is not element specific, and must 
be performed in a laboratory. 
The first instrument designed to measure 
aerosol surface area was the epiphaniometer 
[Baltensperger et al. 1988]. This device mea-
sures the Fuchs, or active surface area, of the 
aerosols by measuring the attachment rate of 
7 Exposure Assessment and Characterization
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radioactive ions. For aerosols less than ap-
proximately 100 nm in size, measurement of 
the Fuchs surface area is probably a good in-
dicator of external surface area (or geometric 
surface area). However, for aerosols greater 
than approximately 1 µm, the relationship 
with geometric particle surface area is lost 
[Fuchs 1964]. Measurements of active surface 
area are generally insensitive to particle po-
rosity. The epiphaniometer is not well suited 
to widespread use in the workplace because 
of the inclusion of a radioactive source and 
the lack of effective temporal resolution. 
This same measurement principle can be 
applied with the use of a portable aerosol 
diffusion charger. Studies have shown that 
these devices provide a good estimate of 
aerosol external surface area when airborne 
particles are smaller than 100 nm in diam-
eter. For larger particles, diffusion chargers 
underestimate aerosol surface area. How-
ever, further research is needed to evaluate 
the degree of underestimation. Extensive 
field evaluations of commercial instruments 
are yet to be reported. However, laboratory 
evaluations with monodisperse silver par-
ticles have shown that two commercially 
available diffusion chargers can provide 
good measurement data on aerosol exter-
nal surface area for particles smaller than 
100 nm in diameter but underestimate the 
aerosol surface area for particles larger than 
100 nm in diameter [Ku and Maynard 2005, 
2006].
7.1.4 Particle number concentration 
measurement
Particle number concentration has been as-
sociated with adverse responses to air pol-
lution in some human studies [Timonen 
et al. 2004; Ruckerl et al. 2005], while in 
toxicologic studies, particle surface area has 
generally been shown to be a better predic-
tor than either particle number, mass, or vol-
ume concentration alone [Oberdörster and 
Yu 1990; Tran et al. 1999; Duffin et al. 2002]. 
A two-variable dose metric of particle size 
and volume has been shown to be the best 
predictor of lung cancer in rats from vari-
ous types of particles [Borm et al. 2004; Pott 
and Roller 2005]. This illustrates some of 
the complexity of interpreting existing data 
on particle dose metric and response. While 
adverse health effects appear to be more 
closely related with particle surface area, the 
number of particles depositing in the respi-
ratory tract or other organ systems may also 
play an important role. 
Aerosol particle number concentration can 
be measured relatively easily using Conden-
sation Particle Counters (CPCs). These are 
available as hand-held static instruments, 
and they are generally sensitive to particles 
greater than 10–20 nm in diameter. Con-
densation Particle Counters designed for the 
workplace do not have discrete size-selective 
inputs, and so they are typically sensitive to 
particles less than 1 µm in diameter. Com-
mercial size- selective inlets are not available 
to restrict CPCs to the nanoparticle size range; 
however, the technology exists to construct 
size- selective inlets based on particle mobil-
ity or possibly on inertial pre-separation. An 
alternative approach to estimating nanopar-
ticle number concentrations using a CPC is 
to use the instrument in parallel with an op-
tical particle counter (OPC). The difference 
in particle count between the instruments 
will provide an indication of particle number 
concentration between the lower CPC de-
tectable particle diameter and the lower OPC 
particle diameter (typically 300–500 nm).
A critical issue when characterizing expo-
sure using particle number concentration 
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is selectivity. Nanoscale particles are ubiq-
uitous in many workplaces, from sources 
such as combustion, vehicle emissions, and 
infiltration of outside air. Particle counters 
are generally insensitive to particle source 
or composition making it difficult to dif-
ferentiate between incidental and pro-
cess-related nanoparticles using number 
concentration alone. In a study of aerosol 
exposures during a carbon black bagging 
process, Kuhlbusch et al. [2004] found that 
peaks in number concentration measure-
ments were associated with emissions from 
fork lift trucks and gas burners in the vicin-
ity, rather than with the process itself. In a 
similar manner, during an ultrafine particle 
mapping exercise in an automotive facility, 
Peters et al. [2006] found that direct gas-
fired heating systems systematically pro-
duced high particle number concentrations 
throughout the facility when the heating 
system was in operation. Through follow 
up measurements, Heitbrink et al. [2007] 
found a high proportion of ultrafine par-
ticles produced from these burners, yet little 
if any mass was associated with their emis-
sions. Other non-process ultrafine sources 
were identified in an adjacent foundry [Ev-
ans et al. 2008]. Together with roof mounted 
gas-fired heating units, additional sources 
included cigarette-smoking and the exhaust 
from a propane fueled sweeper vehicle, with 
the latter contributing a large fraction of the 
ultrafine particles. Although these issues are 
not unique to particle number concentra-
tion measurements, orders of magnitude 
difference can exist in particle number 
concentrations depending on concomitant 
sources of particle emissions. 
Although using nanoparticle number con-
centration as an exposure measurement may 
not be consistent with exposure metrics be-
ing used in animal toxicity studies, such 
measurements may be useful for identify-
ing nanoscale particle emissions and de-
termining the efficacy of control measures. 
Portable CPCs are capable of measuring lo-
calized particle concentrations allowing the 
assessment of particle releases occurring at 
various processes and job tasks [Brouwer et 
al. 2004].
7.1.5 Surface-area estimation
Information about the relationship between 
different measurement metrics can be used 
for approximating particle surface area. If 
the size distribution of an aerosol remains 
consistent, the relationship between particle 
number, surface area, and mass metrics will 
be constant. In particular, mass concentra-
tion measurements can be used for deriving 
surface-area concentrations, assuming the 
constant of proportionality is known. This 
constant is the specific surface area (surface 
to mass ratio). 
Size distribution measurements may be ob-
tained through the collection of filter samples 
and analysis by transmission electron mi-
croscopy to estimate particle surface area. If 
the measurements are weighted by particle 
number, information about particle geom-
etry will be needed to estimate the surface 
area of particles with a given diameter. If the 
measurements are weighted by mass, ad-
ditional information about particle density 
will be required. Estimates of particle-specific 
surface area from geometric relation with ex-
ternal particle dimensions depends upon the 
morphology regime of the material of inter-
est and is only appropriate for smooth, regu-
larly shaped, compact particles [Stefaniak et al. 
2003; Weibel et al. 2005]. For example, Weibel 
et al. [2005] report that estimates of ultrafine 
TiO
2
 surface area determined using a geomet-
ric relationship with the physical particle size 
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(using TEM) were 50% lower than measured 
using nitrogen gas adsorption. 
If the airborne aerosol has a lognormal size 
distribution, particle surface-area concen-
tration can be derived using three indepen-
dent measurements. An approach has been 
proposed using three simultaneous mea-
surements of the aerosol that included mass 
concentration, number concentration, and 
charge [Woo et al. 2001]. With knowledge of 
the response function of each instrument, 
minimization techniques can be used to es-
timate the parameters of the lognormal dis-
tribution leading to the three measurements 
used in estimating the particle surface area. 
An alternative approach has been proposed 
whereby independent measurements of par-
ticle number and mass concentration are 
made, and the surface area is estimated by as-
suming the geometric standard deviation of 
the (assumed) lognormal distribution [May-
nard 2003]. This method has the advantage of 
simplicity by relying on portable instruments 
that can be used in the workplace. Theoreti-
cal calculations have shown that estimates 
may be up to a factor of 10 different from 
the actual particle surface area, particularly 
when the aerosol has a bimodal distribution. 
Field measurements indicate that estimates 
are within a factor of 3 of the active surface 
area, particularly at higher concentrations. 
In workplace environments, particle surface-
 area concentrations can be expected to span 
up to 5 orders of magnitude; thus, surface-
 area estimates may be suited for initial or 
preliminary appraisals of occupational expo-
sure concentrations. 
Although such estimation methods are un-
likely to become a long-term alternative to 
more accurate methods, they may provide 
a viable interim approach to estimating the 
surface area of nanoscale particles in the 
absence of precise measurement data. Ad-
ditional research is needed on comparing 
methods used for estimating particle surface 
area with a more accurate particle surface-
area-measurement method. NIOSH is con-
ducting research in this area and will com-
municate results as they become available. 
7.1.6 Particle number 
concentration mapping
To better understand particle sources and 
contaminant migration, some investigators 
have adopted an aerosol mapping technique, 
which integrated measurements of respi-
rable mass, ultrafine particle number, and 
active surface-area concentrations in auto-
motive manufacturing facilities [Peters et al. 
2006; Heitbrink et al. 2007, 2008; Evans et al. 
2008]. The process relies on portable aerosol 
sampling instrumentation for simultaneous 
measurements at predetermined positions 
throughout a facility. The technique is some-
what measurement-intensive but is useful 
for locating contaminant sources and deter-
mining the extent of contaminant migration. 
Leaks and other less obvious particle sources 
have been identified in this way and the pro-
cedure provides a powerful tool for facil-
ity staff to target their contaminant control 
approaches most effectively. This technique 
relies on successive measurements at various 
locations, making facilities with continuous 
processes or those likely to achieve steady 
state particle number concentrations most 
appropriate for this approach. The approach 
is less successful for facilities with batch pro-
cesses or those likely to experience rapid con-
centration changes as, depending on where 
in the measurement cycle the release occurs, 
it may be overlooked. A high degree of vari-
ability between mapping events is expected in 
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facilities where sporadic or batch processing 
occurs.
7.2 Sampling Strategy
Currently, there is not one sampling method 
that can be used to characterize exposure to 
nanoscale aerosols. Therefore, any attempt to 
characterize workplace exposure to nanoma-
terials must involve a multifaceted approach 
incorporating many of the sampling tech-
niques mentioned above. Brouwer et al. [2004] 
recommend that all relevant characteristics of 
nanomaterial exposure be measured, and a 
sampling strategy similar to theirs would pro-
vide a reasonable approach to characterizing 
workplace exposure. NIOSH has developed 
the Nanoparticle Emission Assessment Tech-
nique (NEAT) to qualitatively determine the 
release of engineered nanomaterials in the 
workplace (see Appendix). This approach may 
be helpful to others for the initial evaluation of 
workplaces where engineered nanomaterials 
are manufactured or used. If material release 
is found and if resources allow, then a more 
comprehensive and quantitative approach 
may be adopted [Methner et al. 2007].
The first step to characterizing workplace ex-
posures would involve identifying the source 
of nanomaterial emissions. A CPC used in 
parallel with an OPC provides acceptable 
capability for this purpose. It is critical to 
determine ambient or background particle 
counts before measuring particle counts 
during the manufacturing, processing, or 
handling of engineered nanomaterials. 
However, investigators need to be aware that 
background nanoscale particle counts can 
vary both spatially and temporally depend-
ing on the unique conditions of the work-
place. Subtraction of background nanoscale 
particle counts will be most challenging in 
these situations. In cases where nanomaterial 
handling or processing operations contrib-
ute only small elevations in particle counts, 
it may not be possible to adequately charac-
terize these increases, particularly if the back-
ground particle count is relatively high. 
If nanomaterials are detected in the pro-
cess area at elevated concentrations rela-
tive to background particle number con-
centrations, then a pair of filter-based, area 
air samples should be collected for particle 
analysis via transmission electron micros-
copy (TEM) and for determining mass con-
centration. Transmission electron micros-
copy can provide an estimate of the particle 
size distribution and, if equipped with an 
energy dispersive X-ray analyzer (EDS), a 
determination of elemental composition 
Figure 7–2. Photomicrographs of airborne engineered nanomaterials (airborne samples 
of engineered nanoparticles of silver, nickel, and MWCNT analyzed by TEM and EDS) 
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can be made to identify the nanomaterial 
(see Figure 7–2).
Analysis of filters for mass determination of 
air contaminants of interest can help identify 
the source of the particles. Standard analyti-
cal chemical methodologies (e.g., NMAM 
5040 for carbon, NMAM 7303 for metals) 
should be employed [NIOSH 1994]. 
The combination of particle counters and 
samples for chemical analysis allows for an 
assessment of worker exposure to nanoma-
terials (see Figure 7–3) and the characteriza-
tion of the important aerosol metrics. How-
ever, since this approach relies primarily on 
static or area sampling, some uncertainty 
will exist in estimating worker exposures. 
Figure 7–3. Combined use of the OPC, 
CPC, and two filter samples to determine 
the presence of nanomaterials
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Engineered nanomaterials are diverse in 
their physical, chemical, and biological na-
ture. The processes used in research, ma-
terial development, production, and use 
or introduction of nanomaterials have the 
potential to vary greatly. Until further in-
formation on the possible health risks and 
extent of occupational exposure to nano-
materials becomes available, interim pro-
tective measures should be developed and 
implemented. These measures should focus 
on the development of engineering controls 
and safe working practices tailored to the 
specific processes and materials where work-
ers might be exposed. Hazard information 
that is available about common materials 
being manufactured in the nanoscale range 
(e.g., TiO
2
,
 
beryllium) should be considered 
as a starting point in developing appropriate 
controls and work practices. 
The following recommendations are de-
signed to aid in the assessment and control 
of workplace exposures to engineered nano-
materials. Using a hazard-based approach to 
evaluate exposures and for developing pre-
cautionary measures is consistent with good 
occupational safety and health practices 
[The Royal Society and The Royal Academy 
of Engineering 2004; Schulte et al. 2008].
8.1 Potential for Occupational 
Exposure
Few workplace measurement data exist on 
airborne exposure to nanomaterials that are 
purposely produced and not incidental to an 
industrial process. In general, it is likely that 
processes generating nanomaterials in the 
gas phase (after removal of the nanomaterial 
from an enclosed generation system), or us-
ing or producing nanomaterials as powders 
or slurries/suspensions/solutions (i.e., in liq-
uid media), pose the greatest risk for releas-
ing nanoparticles. In addition, maintenance 
on production systems (including cleaning 
and disposing of materials from dust collec-
tion systems) is likely to result in exposure 
to nanoparticles if deposited nanomateri-
als are disturbed. Exposures associated with 
waste streams containing nanomaterials may 
also occur.
The magnitude of exposure to nanomaterials 
when working with nanopowders depends 
on the likelihood of particles being released 
from the powders during handling. NIOSH 
is actively conducting research to quantita-
tively determine how various nanomaterials 
are dispersed in the workplace. Studies on 
exposure to SWCNTs and MWCNTs have in-
dicated that the raw material may release vis-
ible particles into the air when handled, that 
the particle size of the agglomerate can be a 
few millimeters in diameter, and that the re-
lease rate of inhalable and respirable particles 
is relatively low (on a mass or number basis) 
compared with other nanopowders. May-
nard et al. [2004] reported concentrations of 
respirable dust from 0.007 to 0.053 mg/ m3 
when energy was applied (vortexing) to 
bulk SWCNT for approximately 30 minutes. 
Similar findings were reported by Han et al. 
[2008] at a laboratory producing MWCNTs 
in which exposure concentrations as high as 
0.4 mg/ m3 were observed prior to the imple-
mentation of exposure controls. In a health 
hazard evaluation conducted by NIOSH at a 
Guidelines for Working with Engineered 
Nanomaterials8
36 Approaches to Safe Nanotechnology
8 Guidelines for Working with Engineered Nanomaterials 8 Guidelines for Working with Engineered Nanomaterials
university-based research laboratory the po-
tential release of airborne carbon nanotubes 
(CNFs) was observed at various processes 
[Methner et al. 2007]. General area exposure 
measurements indicated slight increases in 
airborne particle number and mass concen-
trations relative to background measure-
ments during the transfer of CNFs prior to 
weighing and mixing, and during wet saw 
cutting of a composite material. Since data 
are lacking on the generation of inhalable/
respirable particles during the production 
and use of engineered nanomaterials, fur-
ther research is required to determine ex-
posures under various conditions. NIOSH 
researchers are conducting both laboratory 
and field-based evaluations in order to ad-
dress some of these knowledge gaps.
Devices comprised of nanostructures, such 
as integrated circuits, pose a minimal risk 
of exposure to nanomaterials during han-
dling. However, some of the processes used 
in their production may lead to exposure 
to nanomaterials (e.g., exposure to com-
mercial polishing compounds that contain 
nanoscale particles, exposure to nanoscale 
particles that are inadvertently dispersed or 
created during the manufacturing and han-
dling processes). Likewise, large-scale com-
ponents formed from nanocomposites will 
most likely not present significant exposure 
potential. However, if such materials are 
used or handled in such a manner that can 
generate nanoparticles (e.g., cutting, grind-
ing) or undergo degradation processes that 
lead to the release of nanostructured mate-
rial, then exposure may occur by the inhala-
tion, ingestion, and/or dermal penetration 
of these particles.
8.2 Factors Affecting Exposure 
to Nanomaterials
Factors affecting exposure to engineered 
nanomaterials include the amount of mate-
rial being used and whether the material can 
be easily dispersed (in the case of a powder) 
or form airborne sprays or droplets (in the 
case of suspensions). The degree of contain-
ment and duration of use will also influence 
exposure. In the case of airborne material, 
particle or droplet size will determine wheth-
er the material can enter the respiratory tract 
and where it is most likely to deposit. Respi-
rable particles are those capable of depositing 
in the alveolar (gas exchange) region of the 
lungs, which includes particles smaller than 
approximately 10 µm in diameter [Lippmann 
1977; ICRP 1994; ISO 1995]. The proportion 
of inhaled nanoparticles likely to deposit in 
any region of the human respiratory tract is 
approximately 30%–90% depending on fac-
tors such as breathing rate and particle size. 
Up to 50% of nanoparticles in the 10–100 nm 
size range may deposit in the alveolar region, 
while nanoparticles smaller than 10 nm are 
more likely to deposit in the head and tho-
racic regions [ICRP 1994]. The mass deposi-
tion fraction of inhaled nanoparticles in the 
gas-exchange region of the lungs is greater 
than that for larger respirable particles.
At present there is insufficient information 
to predict all of the situations and workplace 
scenarios that are likely to lead to exposure 
to nanomaterials. However, there are some 
workplace factors that can increase the po-
tential for exposure:
working with nanomaterials in liquid •	
media without adequate protection 
(e.g., gloves)
working with nanomaterials in liquid •	
during pouring or mixing operations 
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or where a high degree of agitation is 
involved 
generating nanomaterials in the gas phase •	
in non-enclosed systems 
handling (e.g., weighing, blending, spray-•	
ing) powders of nanostructured materials 
maintenance on equipment and process-•	
es used to produce or fabricate nanoma-
terials 
cleaning up spills or waste material •	
cleaning dust collection systems used •	
to capture nanoparticles 
machining, sanding, drilling of nano-•	
materials, or other mechanical disrup-
tions of nanomaterials can potentially 
lead to the aerosolization of nanopar-
ticles. 
8.3 Elements of a Risk 
Management Program
Given the limited information about the 
health risks associated with occupational 
exposure to engineered nanomaterials, ap-
propriate steps should be taken to minimize 
the risk of worker exposure through the 
implementation of a risk management pro-
gram [Schulte et al. 2008]. Risk management 
programs for nanomaterials should be seen 
as an integral part of an overall occupational 
safety and health program for any company 
or workplace producing or using nanomate-
rials or nanoenabled products. A critical ele-
ment of the program should be the capability 
to anticipate new and emerging risks (hazard 
determination) and whether they are linked 
to changes in the manufacturing process, 
equipment, or the introduction of new ma-
terials. This will require an ongoing assess-
ment of the potential risks to workers (risk 
evaluation) through the systematic collection 
of job and product information so that de-
terminations can be made regarding scenari-
os (e.g., laboratory research, production and 
manufacture, nanoenabled product use) that 
place the worker in contact with nanomateri-
als (see Figure 8–1). This assessment should 
be an ongoing cyclic process that provides 
feedback on potential sources of exposure 
and solutions taken to correct those prob-
lems. For example, operations and job tasks 
that have the potential to aerosolize nanoma-
terials (e.g., handling dry powders, spray ap-
plications) deserve more attention and more 
stringent controls than those where the nano-
materials are imbedded in solid or liquid ma-
trices. Elements of the risk management pro-
gram should include guidelines for installing 
and evaluating engineering controls (e.g., 
exhaust ventilation, dust collection systems), 
the education and training of workers in the 
proper handling of nanomaterials (e.g., good 
work practices), and the selection and use of 
personal protective equipment (e.g., cloth-
ing, gloves, respirators). 
When controlling potential exposures within 
a workplace, NIOSH has recommended a 
hierarchical approach to reduce worker ex-
posures (see Table 8–1) [NIOSH 1990]. The 
philosophical basis for the hierarchy of con-
trols is to eliminate the hazard when possible 
(i.e., substitute with a less hazardous mate-
rial) or, if not feasible, control the hazard at 
or as close to the source as possible. 
8.3.1 Engineering Controls
If the potential hazard can not be eliminat-
ed or substituted with a less hazardous or 
non-hazardous substance, then engineer-
ing controls should be installed and tai-
lored to the process or job task. The type of 
engineering control used should take into 
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Figure 8–1. Workplaces with potential for occupational exposure to engineered 
nanomaterials. The figure illustrates the life cycle of nanomaterials from laboratory 
research development through product development, use, and disposal. Each step of 
the life cycle represents opportunities for potential worker exposure to nanomaterials. 
Adapted from Schulte et al. 2008a. 
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account information on the potential haz-
ardous properties of the precursor materi-
als and intermediates as well as those of the 
resulting nanomaterial. In light of current 
scientific knowledge about the generation, 
transport, and capture of aerosols [Seinfeld 
and Pandis 1998; Hinds 1999], airborne ex-
posure to nanomaterials can most likely be 
controlled at most processes and job tasks 
using a wide variety of engineering control 
techniques similar to those used in reducing 
exposures to general aerosols [Ratherman 
1996; Burton 1997]. 
Engineering control techniques such as 
source enclosure (i.e., isolating the genera-
tion source from the worker) and local ex-
haust ventilation systems should be effective 
for capturing airborne nanomaterials, based 
on what is known of nanomaterial motion 
and behavior in air (see Figure 8–2). The 
quantity of the bulk nanomaterial that is 
synthesized or handled in the manufacture 
of a product will significantly influence the 
selection of the exposure controls. 
Other factors that influence selection of engi-
neering controls include the physical form of 
the nanomaterial and task duration and fre-
quency. For instance, working with nanomate-
rial in the slurry form in low quantities would 
require a less rigorous control system than 
those that would be required for large quan-
tities of nanomaterials in a free or fine pow-
der form (see Figure 8–3). Unless cutting or 
grinding occurs, nanomaterials that are not in 
free form (encapsulated in a solid, nanocom-
posites, and surface coated materials) typically 
wouldn’t require engineering controls. 
Handling research quantities typically oc-
curs in laboratories with ventilation con-
trols. Since quantities are small, local con-
tainment and control can be applied, such 
as low-flow vented work stations and small 
glove box chambers. However, as quantities 
are increased, care must be taken to reduce 
the amount of nanomaterial that is released 
from the process equipment and to pre-
vent the migration of nanomaterials into 
adjacent rooms or areas. For example, the 
installation of local exhaust ventilation at a 
Table 8–1. Hierarchy of exposure controls* 
Control method Process, equipment, or job task 
1. Elimination Change design to eliminate hazard
2. Substitution Replace a high hazard for a low hazard
3. Engineering Isolation/enclosure, ventilation (local, general)
4. Administrative Procedures, policies, shift design
5. Personal protective equipment Respirators, clothing, gloves, goggles, ear plugs
*Control methods are typically implemented in this order to limit worker exposures to an acceptable 
concentration (e.g., occupational exposure limit or other pre-established limit). 
Sources: Plog et al. 2002; NIOSH 1990.
40 Approaches to Safe Nanotechnology
8 Guidelines for Working with Engineered Nanomaterials 8 Guidelines for Working with Engineered Nanomaterials
reactor used to make nanoscale engineered 
metal oxides and metals was found to re-
duce nanoparticle exposures by 96% (mean 
particle number concentration) [Methner 
2008]. The use of exhaust ventilation sys-
tems should be designed, tested, and main-
tained using approaches recommended by 
the American Conference of Governmental 
Industrial Hygienists [ACGIH 2001]. 
A secondary but nonetheless important 
issue concerning the control of nanopar-
ticle emissions is that of product loss. The 
properties of nanomaterials, along with the 
unique methods that may be employed for 
producing them, may mean that traditional 
exhaust ventilation may be more energetic 
than necessary for removing incidentally 
released nanoscale particles. For this rea-
son, engineering controls need to be applied 
judiciously to ensure protection of workers 
without compromising production.
8.3.2 Dust collection efficiency of 
filters
Current knowledge indicates that a well-
 designed exhaust ventilation system with a 
Figure 8–2. Exposure control of particles (illustration of how particle diameter-related 
diffusion and inertia influence particle capture efficiency in a ventilation system). Particles 
with a diameter of 200–300 nm have minimal diffusion and inertial properties and are 
easily transported by moving air and captured. Particle motion by diffusion increasingly 
dominates as particle diameter decreases below 200 nm. The inertial behavior of larger 
particles, especially those ejected from energetic processes such as grinding, increases 
significantly with particle diameter, enabling them to cross the streamlines of moving air 
and avoid capture. Adapted from Schulte et al. 2008a.
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HEPA filter should effectively remove nano-
particles [Hinds 1999]. Limited studies have 
reported the efficacy of filter media typically 
found in control systems (including respira-
tors) in capturing nanoparticles. The dearth 
of data on filtration performance against 
nanoparticles (in particular nanoparticles 
smaller than 20 nm) is primarily due to the 
challenges in generating and quantifying 
particles in those size ranges. Despite these 
limitations, the results of some studies [Van 
Osdell et al. 1990] using different filter me-
dia challenged with monodispersed aero-
sols (silver 4–10 nm and dioctylphthalate 
32–420 nm) were in agreement with classical 
single-fiber theory showing an increase in fil-
tration efficacy for smaller size particles. No 
evidence for particle thermal rebound was 
observed. Similar results have been recently 
reported by Kim et al. [2007] using different 
filter media challenged with particles ranging 
in size from 2.5–20 nm, indicating that other 
filter medias—including those used in air pu-
rifying respirators—would behave similarly. 
If HEPA filters are used in the dust collec-
tion system, they should be coupled with 
well- designed filter housings. If the filter 
is improperly seated within the housing, 
nanoparticles have the potential to bypass 
the filter, leading to filter efficiencies much 
less than predicted [NIOSH 2003]. 
8.3.3 Work practices 
An integral step in establishing good work 
practices is having knowledge of the potential 
Figure 8–3. Factors influencing control selection. Several factors influence the selection of 
exposure controls for nanomaterials including quantity of nanomaterial handled or produced, 
physical form, and task duration. As each one of theses variables increase, exposure risk 
becomes greater as does the need for more efficient exposure control measures. 
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hazards in the workplace and developing 
formal procedures that describe actions to 
be taken to ensure the protection of workers. 
Incorporated in these procedures should be 
guidelines for good work practices intended 
to minimize worker exposure to nanomate-
rials and other potentially hazardous chem-
icals. Management should systemically re-
view and update these procedures. Actions 
taken to resolve and/or improve workplace 
conditions should be routinely conveyed by 
management to workers. 
Good practices for management
Educating workers on the safe han-•	
dling of engineered nano-objects or 
nano-object-containing materials to 
minimize the likelihood of inhalation 
exposure and skin contact. 
Providing information, as needed, on •	
the hazardous properties of the precur-
sor materials and those of the resulting 
nanomaterials product with instruc-
tion on measures to prevent exposure.
Encouraging workers to use hand-•	
 washing facilities before eating, smok-
ing, or leaving the worksite. 
Providing additional control measures •	
(e.g., use of a buffer area, decontamina-
tion facilities for workers if warranted 
by the hazard) to ensure that engineered 
nanomaterials are not transported out-
side the work area [US DOE 2007].
Providing facilities for showering and •	
changing clothes to prevent the inad-
vertent contamination of other areas 
(including take-home) caused by the 
transfer of nanomaterials on clothing 
and skin. 
Good practices for workers
Avoiding handling nanomaterials in •	
the open air in a ‘free particle” state. 
Storing dispersible nanomaterials, wheth-•	
er suspended in liquids or in a dry particle 
form in closed (tightly sealed) containers 
whenever possible.
Cleaning work areas at the end of each •	
work shift, at a minimum, using either 
a HEPA-filtered vacuum cleaner or wet 
wiping methods. Dry sweeping or air 
hoses should not be used to clean work 
areas. Cleanup should be conducted in 
a manner that prevents worker contact 
with wastes. Disposal of all waste mate-
rial should comply with all applicable 
Federal, State, and local regulations.
Avoiding storing and consuming food •	
or beverages in workplaces where nano-
materials are handled. 
8.3.4 Personal protective clothing 
Currently, there are no generally acceptable 
guidelines available based on scientific data 
for the selection of protective clothing or 
other apparel against exposure to nanoma-
terials. This is due in part to minimal data 
being available on the efficacy of existing 
protective clothing, including gloves. In any 
case, although nanoparticles may penetrate 
the epidermis, there has been little evidence 
to suggest that penetration leads to disease; 
and no dermal exposure standards have been 
proposed. However, based on a recent survey 
of nanotechnology workplaces [ICON 2006], 
84% of employers recommended personal 
protective equipment and clothing for em-
ployees working with nanomaterials. These 
recommendations were generally based on 
conventional occupational hygiene practices 
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but also varied with the size of the company, 
the type of nanomaterials being handled, and 
the commercial sector. While some guide-
lines on the use of protective clothing and 
gloves have been developed by organizations 
for use in their own laboratories (e.g., US 
DOE 2007) or countries (e.g., British Stan-
dards Institute BSI 2008) or by consensus 
standards development organizations (e.g., 
ASTM, 2007), these are generally based upon 
good industrial hygiene practices rather than 
scientific data specific to nanomaterials. 
A challenge to making appropriate recom-
mendations for dermal protection against 
nanoparticles is the need to strike a balance 
between comfort and protection. Garments 
that provide the highest level of protection 
(e.g., an impermeable Level A suit) are also 
the least comfortable to wear for long peri-
ods of time, while garments that are probably 
the least protective (e.g., thin cotton lab coat) 
are the most breathable and comfortable for 
employees to wear. The two primary routes 
of exposure to particulates for workers us-
ing protective clothing are direct penetration 
through the materials and leakage through 
gaps, seams, defects, and interface and clo-
sure areas [Schneider et al. 1999, 2000]. The 
relative contributions from these two inward 
leakage sources are not well-understood. 
NIOSH has an active research program de-
signed to assess the efficacy of barrier materi-
als and ensembles for protection against par-
ticulate hazards, including nanoparticles. 
The lack of available data is further compli-
cated by the limitations and difficulties of 
current test methods, which fall into two ba-
sic categories: penetration tests on material 
swatches to determine barrier efficiency and 
system-level aerosol testing to determine 
product ensemble integrity. The former are 
usually bench-scale testing methods, while 
the latter require an exposure chamber that 
is large enough for at least one human test 
subject or mannequin. Chamber design re-
quirements for system level aerosol testing 
have been reviewed by Gao et al. [2007]. 
Little scientific data exists, but some systems 
level test methods are available. ISO standard 
method 13982 [ISO 2004a] and EN stan-
dard method 943 [CEN 2002] specify the 
use of sodium chloride (NaCl) with a mass 
median aerodynamic diameter (MMAD) of 
0.6 µm to determine the barrier efficiency of 
protective clothing against aerosols of dry, 
fine dusts. The standard method issued by 
National Fire Protection Association [2007] 
is a method that is not dependent on filtra-
tion-based approaches. Penetration of fluo-
rophore-impregnated silica particles with a 
MMAD of 2.5 µm and a geometric standard 
deviation of 2.6 are qualitatively visualized 
by black light that causes the fluorescent 
glow of the challenge aerosol particles. Note 
that the polydisperse particle challenges 
used in these methods include a large num-
ber of nanoscale particles when measured 
by count rather than by mass. 
Particle penetration test methods can be fur-
ther categorized into those that are analogous 
to the process used in respirator filter testing 
and those that are not dependent on filtra-
tion-based approaches. Test methods that in-
volve measuring aerosol concentrations us-
ing a sampling flow rate do not mimic in-situ 
situations because the skin does not “breathe.” 
Standardized methodology is needed that is 
not dependent on filtration-based approaches 
for examining the overall barrier-effectiveness 
of the full protective clothing ensemble for dif-
ferent materials to particulate hazards. In this 
respect, NIOSH has presented preliminary re-
sults [Wang and Gao 2007] on development 
of a magnetic passive aerosol sampler for more 
accurate determination of particle penetration 
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through protective clothing. NIOSH is con-
ducting research in this area and will commu-
nicate results as they become available. 
The bulk of the penetration data available 
on clothing has been done with filtration 
based testing. One study found that pen-
etration levels of 30–2,000-nm-sized potas-
sium chloride particles through an uniden-
tified military garment ranged from about 
20%–60%, with the maximum penetration 
occurring in the range of 100–400 nm [Ho-
facre 2006]. Another group of researchers 
studied the barrier efficiency of 10 uniden-
tified fabric samples (woven, non-woven, 
and laminated fabrics) using 477-nm-sized 
latex spheres at a flow rate of 1.8 cm/second 
[Shavlev et al. 2000]. Particle penetration 
measurements ranged from 0%–54%, with 
three of the fabrics exhibiting a measurable 
pressure drop and having penetration lev-
els less than 1%. In general, these findings 
suggest that increased external air pressure 
(e.g., from wind) results in increased particle 
penetrations. Thus, only impermeable bar-
rier materials are likely to provide complete 
barrier protection against aerosol penetra-
tion. Body movement (i.e., bellows effect) 
can also impact penetration [Bergman et al. 
1989]. NIOSH will theoretically and empir-
ically investigate wind-driven nanoparticle 
penetration through protective clothing 
in an attempt to obtain a predictive model 
based upon single-fiber theory. Results will 
be communicated as they become available.
Another widely used test method incor-
porates testing with nanoscale particles in 
solution, and therefore also provides some 
indication of the effectiveness of protective 
clothing to nanoparticles. ASTM standard 
F1671–03 [ASTM 2003] and ISO standard 
16604 [ISO 2004b] specify the use of a 27-nm 
bacteriophage to evaluate the resistance of 
materials used in protective clothing from 
the penetration of blood-borne pathogens. 
One study [Edlich et al. 1999] evaluated the 
integrity of powder-free examination gloves 
and found that no bacteriophage penetra-
tion was detected for powder-free nitrile 
gloves, powder-free latex gloves, nor polyvi-
nyl chloride synthetic gloves. 
Based upon the uncertainty of the health ef-
fects of dermal exposure to nanoparticles, it 
is prudent to consider using protective equip-
ment, clothing, and gloves to minimize der-
mal exposure, with particular attention given 
to preventing exposure of nanomaterials to 
abraded or lacerated skin. Until scientific data 
exist specific to the performance of protec-
tive clothing and gloves against nanomateri-
als, current industrial hygiene best practices 
should be followed. 
8.3.5 Respirators 
The use of respirators is often required when 
engineering and administrative controls do 
not adequately keep worker exposures to 
an airborne contaminant below a regula-
tory limit or an internal control target. Cur-
rently, there are no specific exposure limits 
in the United States for airborne exposures 
to engineered nanomaterials although oc-
cupational exposure limits and guidelines 
exist for airborne particles of similar chemi-
cal composition regardless of particle size. 
Current scientific evidence indicates that 
nanoparticles may be more biologically re-
active than larger particles of similar chemi-
cal composition and thus may pose a greater 
health risk when inhaled. In determining the 
need for respirators, it would therefore be 
prudent to consider current exposure lim-
its or guidelines (e.g., OSHA PELs, NIOSH 
RELs, ACGIH TLVs) for larger particles of 
similar composition, existing toxicologic 
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data on the specific nanoparticle, and the 
likelihood of worker exposure (e.g., airborne 
concentration, time exposed, job task). 
The decision to institute respiratory pro-
tection should be based on a combination 
of professional judgment and the results 
of the hazard assessment and risk manage-
ment practices recommended in this docu-
ment. The effectiveness of administrative, 
work-practice, and engineering controls 
can be evaluated using the measurement 
techniques described in Chapter 7 Expo-
sure Assessments and Characterization. If 
worker exposure to airborne nanomaterials 
remains a concern after instituting control 
measures, the use of respirators can provide 
further worker protection. Several classes of 
respirators exist that can provide different 
levels of protection when properly fit tested 
on the worker. Table 8–2 lists various types 
of particulate respirators that can be used; 
information is also provided on the level 
of exposure reduction that can be expected 
along with the advantages and disadvantages 
of each respirator type. To assist respirator 
users, NIOSH has published the document 
NIOSH Respirator Selection Logic (RSL) that 
provides a process that respirator program 
administrators can use to select appropriate 
respirators [NIOSH 2004] (see www.cdc.
gov/niosh/docs/2005-100/default.html). As 
new toxicity data for individual nanomate-
rials become available, NIOSH will review 
the data and make recommendations for 
respirator protection. 
When respirators are required for use in 
the workplace, the Occupational Safety and 
Health Administration (OSHA) respiratory 
protection standard [29 CFR 1910.134] re-
quires that a respiratory program be estab-
lished that includes the following program 
elements: (1) an evaluation of the worker’s 
ability to perform the work while wearing 
a respirator, (2) regular training of person-
nel, (3) periodic environmental monitoring, 
(4) respirator fit testing, and (5) respira-
tor maintenance, inspection, cleaning, and 
storage. The standard also requires that the 
selection of respirators be made by a person 
knowledgeable about the workplace and the 
limitations associated with each type of res-
pirator. OSHA has also issued guidelines for 
employers who choose to establish the vol-
untary use of respirators [29 CFR 1910.134 
Appendix D].
Table 8–2 lists the NIOSH assigned pro-
tection factors (APF) for various classes of 
respirators. The APF is defined as the mini-
mum anticipated protection provided by a 
properly functioning respirator or class of 
respirators to a given percentage of prop-
erly fitted and trained users. The APF values 
developed by NIOSH are based in part on 
laboratory studies and take into consider-
ation a variety of factors including the in-
ward leakage caused by penetration through 
the filter and leakage around the respirator 
face seal. The relative contributions of these 
two sources of inward leakage are critical 
because for many applications the predomi-
nant source of exposure to the respirator 
wearer results from leakage around the face 
seal (due to a poor fit) and not penetration 
directly through the filter media. In 2006, 
OSHA published updated APF values that 
supersede the NIOSH APF values [Federal 
Register 2006]. In general there is good 
agreement between the NIOSH and OSHA 
APF values, but management should con-
sult the OSHA standard prior to using the 
values in Table 8–2 directly. 
NIOSH is not aware of any data specific 
to respirator face seal leakage of nanopar-
ticles. However, numerous studies have 
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been conducted on larger particles and on 
gases/vapors with one total inward leakage 
(TIL) study that used nanoparticles. For ex-
ample, work done by researchers at the U.S. 
Army RDECOM on a head-form showed 
that mask leakage (i.e., simulated respira-
tor fit factor) measured using submicron 
aerosol challenges (0.72 µm polystyrene 
latex spheres) was representative of vapor 
challenges such as sulfur hexafluoride (SF
6
) 
and isoamyl acetate (IAA) [Gardner et al. 
2004]. Other studies using particles larger 
than 100 nm have shown that face seal leak-
age can be affected by particle size, howev-
er, the impact of this is still the subject of 
some debate. A recently completed labora-
tory study to measure TIL protection fac-
tors of four NIOSH certified N95 filtering 
facepiece respirator models donned by hu-
man test subjects exposed to 40–1,300 nm 
particles found that the minimal protection 
factors were observed for particles between 
80–200 nm [Lee 2008]. The geometric mean 
of the protection factors for all four models 
across all particle sizes tested was 21.5; but 
wide model-to-model variation was ob-
served. NIOSH is conducting a laboratory 
study to determine whether nanoparticle 
face seal leakage is consistent with the leak-
age observed for larger particles and gases/
vapors. Results will be communicated as 
they become available. 
NIOSH certifies respirators in accordance 
with 42 CFR Part 84. As noted earlier, the 
NIOSH RSL contains a process for select-
ing respirators for protection against par-
ticular hazards. The two respirator classes 
(air purifying respirators and powered air 
purifying respirators) most commonly used 
for protection against particulates use filter 
media to collect/trap particles before they 
reach the user’s breathing zone. Among the 
various test methods and criteria NIOSH 
uses as part of the certification process, 
respirator filter performance testing is the 
one most affected by the particle size. Since 
respirator users are exposed to a variety of 
hazards in different scenarios, respirator 
certification filtration testing was designed 
to use worst-case test conditions (e.g., dif-
ferent particle sizes and flow rates), so that 
filter performance in the workplace would 
not be worse. The NIOSH certification test 
for N-designated respirators uses a polydis-
perse distribution of NaCl particles with a 
count median diameter (CMD) of 0.075 
+/-0.020 µm and a geometric standard de-
viation (GSD) of less than 1.86 [NIOSH 
2005a]. NIOSH tests R- and P-designated 
respirators using a polydispersal of dioctyl 
phthalate (DOP) particles with a CMD of 
0.185 +/-0.020 µm and a GSD of less than 
1.60 [NIOSH 2005b]. For the lognormal 
distribution of NaCl aerosols used in the 
N series certification test, a broad range of 
particle sizes (e.g., 95% of the particles lie 
in the range of 22–259 nm) with a MMD of 
about 240 nm is used to determine whether 
the respirator filter performance is at least 
95, 99, or 99.97% efficient. Most of the par-
ticles penetrating through the filter are mea-
sured simultaneously using a forward light 
scattering photometer. However, as noted in 
a recent review, the instrumentation used in 
the NIOSH certification test is not capable 
of measuring the light scattering of all parti-
cles less than 100 nm [Eninger et al. 2008a].
Particles larger than 0.3 µm are collected 
most efficiently by impaction, interception, 
and gravitational settling, while particles 
smaller than 0.3 µm are collected most ef-
ficiently by diffusion or electrostatic attrac-
tion [Hinds 1999]. In the development of 
the test method used for respirator certifi-
cation, penetration by particles with an ap-
proximate 0.3 µm diameter was considered 
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to be the worst case because these particles 
were considered to be in the range of the 
most penetrating particle size [Stevens and 
Moyer 1989; TSI 2005; NIOSH 1996]. How-
ever, in practice, the most penetrating parti-
cle size range (MPPS) for a given respirator 
can vary based on the type of filter media 
employed and the condition of the respira-
tor. For example, the most penetrating par-
ticle size for N95 air purifying respirators 
containing electrostatically charged filter 
media can range from 50–100 nm [Martin 
and Moyer 2000; Richardson et al. 2005] to 
30–70 nm [Balazy et al. 2006; Eninger et al. 
2008b]. These test results were recently con-
firmed by NIOSH [Rengasamy et al. 2007] 
in which five different models of respirators 
with N95 filters were challenged with 11 dif-
ferent monodisperse NaCl particles ranging 
in size from 20–400 nm. The monodisperse 
aerosol penetrations showed that the MPPS 
was in the 40-nm range for all respirator 
models tested. Under the aggressive labora-
tory test conditions employed in the study, 
mean penetration levels for 40-nm particles 
ranged from 1.4%–5.2%, which suggested 
that the respirators would be effective at 
capturing nanoparticles in the workplace. 
The NIOSH study also investigated whether 
there was a correlation between filtration 
performance using the existing NIOSH 
certification protocol for N series air puri-
fying respirators and the filtration perfor-
mance against monodisperse particles at the 
MPPS. A good correlation (r = 0.95) was 
found (e.g., respirators that performed bet-
ter using the NIOSH certification test also 
had higher filter efficiencies against mono-
disperse 40-nm nanoparticles), which is not 
surprising given that changes in filtration 
performance follow a consistent trend as a 
function of particle size.
According to single fiber filtration theory, 
below the most penetrating particle size, 
filtration efficiency will increase as particle 
size decreases. This trend will continue until 
the particles are so small that they behave 
like vapor molecules. As particles approach 
molecular size, they may be subject to ther-
mal rebound effects, in which particles lit-
erally bounce through a filter. As a result, 
particle penetration will increase. The exact 
size at which thermal rebound will occur 
is unclear. However, a study by Heim et al. 
[2005] found that there was no discernable 
deviation from classical single-fiber theory 
for particles as small as 2.5-nm diameter. 
Subsequently, a NIOSH-funded contract 
with the University of Minnesota [Kim et 
al. 2007; Pui et al. 2006] and another study 
[Kim et al. 2006] showed that the penetra-
tion of nanoparticles through fibrous filter 
media decreased down to 2.5 nm as expect-
ed by the single fiber filtration theory. Ther-
mal rebound phenomena were observed for 
nanoparticles below 2 nm diameter [Kim 
et al. 2006]. Recent studies provide addi-
tional data on nanoparticle penetration 
for NIOSH certified N95 and P100 filter-
ing face-piece respirators [Rengasamy et al. 
2008a], NIOSH certified N95 and Europe-
an Certified FFP1 respirators [Huang et al. 
2007], and FFP3 filter media [Golanski et al. 
2008] using particles greater than 4 nm. 
Based on these preliminary findings, 
NIOSH-certified respirators should provide 
the expected levels of protection if properly 
selected and fit tested as part of a complete 
respiratory protection program. However, 
as noted elsewhere [Rengsamy et al. 2007], 
in the unlikely event that the workplace ex-
posure consists of a large percentage of par-
ticles in the most penetrating particle size 
range, management should take this infor-
mation into account during the respirator 
48 Approaches to Safe Nanotechnology
8 Guidelines for Working with Engineered Nanomaterials 8 Guidelines for Working with Engineered Nanomaterials
selection process, perhaps by choosing a res-
pirator with higher levels of filtration per-
formance (e.g., changing from an N95 to a 
P100, even though the APF will remain the 
same) as suggested by OSHA [Federal Reg-
ister 2006] or by selecting a respirator with 
a higher APF (e.g., full face-piece respirator 
or powered air purifying respirator). Dust 
masks, commercially available at hardware/
home improvement stores, are often con-
fused with NIOSH approved N95 filtering 
facepiece respirators because of their simi-
lar appearance. However, dust masks are not 
respirators and are not approved by NIOSH 
for respiratory protection. One study found 
that penetration of 40-nm NaCl nanopar-
ticles range from 4.3%–81.6% for the seven 
dust mask models studied [Rengasamy et al. 
2008b]. Dust masks should not be used in 
place of NIOSH-approved respirators for 
protection against nanoparticles. 
NIOSH is continuing to study the pro-
tection afforded by NIOSH-certified res-
pirators against emerging hazards such 
as engineered nanomaterials—including 
workplace- protection-factor studies—to en-
sure they provide expected levels of protec-
tion. NIOSH is also committed to updating 
42 CFR Part 84—the regulatory language 
that provides NIOSH the authority to cer-
tify the performance of respirators in the 
United States—using a modular approach 
to rulemaking. Recently, NIOSH proposed 
the use of a TIL test as part of the respira-
tor certification process for half-mask air 
purifying particulate respirators, includ-
ing those having elastomeric and filtering 
face-pieces. The test protocol used to obtain 
benchmark TIL data for 101 half-face piece 
respirator models used 40–60 nm size am-
bient nanoparticles [NIOSH 2007]. Once 
implemented as part of the NIOSH certifi-
cation process, the TIL tests should result in 
half-mask respirators with increased fitting 
performance. Future rulemaking activities 
may also include revisions to the filtration 
test to reflect changes in filtration perfor-
mance resulting from use of new technolo-
gies (e.g., electret filter media). Results will 
be communicated as they become available.
8.3.6 Cleanup and disposal of 
nanomaterials
No specific guidance is currently available on 
cleaning up nanomaterial spills or contamina-
tion on surfaces; however, recommendations 
developed in the pharmaceutical industry for 
the handling and cleanup of pharmaceutical 
compounds might be applicable to worksites 
where engineered nanomaterials are manu-
factured or used [Wood 2001]. Until relevant 
information is available, it would be prudent 
to base strategies for dealing with spills and 
contaminated surfaces on current good prac-
tices, together with available information on 
exposure risks including the relative impor-
tance of different exposure routes. Standard 
approaches for cleaning powder spills in-
clude using HEPA-filtered vacuum cleaners, 
or wiping up the powder using damp cloths 
or wetting the powder prior to dry wiping. 
Liquid spills are typically cleaned by applying 
absorbent materials/liquid traps. 
Damp cleaning methods with soaps or 
cleaning oils are preferred. Cleaning cloths 
should be properly disposed. Use of com-
mercially available wet or electrostatic mi-
crofiber cleaning cloths may also be effective 
in removing particles from surfaces with 
minimal dispersion into the air. Drying and 
reusing contaminated cloths can result in 
re-dispersion of particles.
Energetic cleaning methods such as dry 
sweeping or the using of compressed air 
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should be avoided or only used with precau-
tions that assure that particles suspended 
by the cleaning action are trapped by HEPA 
filters. If vacuum cleaning is employed, care 
should be taken that HEPA filters are installed 
properly and bags and filters changed accord-
ing to manufacturer’s recommendations. 
While vacuum cleaning may prove to be ef-
fective for many applications, the following 
issues should be considered. Forces of attrac-
tion may make it difficult to entrain parti-
cles off surfaces with a vacuum cleaner. The 
electrostatic charge on particles will cause 
them to be attracted to oppositely charged 
surfaces and repelled by similarly charged 
surfaces. A similarly charged vacuum brush 
or tool may repel particles, making it diffi-
cult to capture the aerosol or even causing 
it to be further dispersed. Vigorous scrub-
bing with a vacuum brush or tool or even 
the friction from high flow rates of material 
or air on the vacuum hose can generate a 
charge. The vacuum cleaners recommended 
for cleaning copier and printer toners have 
electrostatic-charge-neutralization features 
to address these issues. 
When developing procedures for cleaning 
up nanomaterial spills or contaminated 
surfaces, consideration should be given to 
the potential for exposure during cleanup. 
Inhalation exposure and dermal exposure 
will likely present the greatest risks. Consid-
eration will therefore need to be given to ap-
propriate levels of personal protective equip-
ment. Inhalation exposure in particular will 
be influenced by the likelihood of material 
reaerosolization. In this context, it is likely 
that a hierarchy of potential exposures will 
exist, with dusts presenting a greater inha-
lation exposure potential than liquids, and 
liquids in turn presenting a greater poten-
tial risk than encapsulated or immobilized 
nanomaterials and structures.
As in the case of any material spill or cleaning 
of contaminated surfaces, the handling and 
disposal of the waste material should follow 
existing federal, state, or local regulations.
Table 8–2. Air-purifying particulate respirators 
Respirator 
type 
NIOSH 
assigned 
protection 
factor Advantages Disadvantages 
Filtering facepiece 
(disposable)
10 – Lightweight
– No maintenance or cleaning 
needed
– No effect on mobility 
– Provides no eye protection
– Can add to heat burden
– Inward leakage at gaps in face 
seal
– Some do not have adjustable 
head straps
– Difficult for a user to do a seal 
check
– Level of protection varies greatly 
among models
– Communication may be difficult
(continued)
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Table 8–2 (Continued). Air-purifying particulate respirators 
Respirator 
type 
NIOSH 
assigned 
protection 
factor Advantages Disadvantages 
Filtering facepiece 
(disposable) 
(continued)
– Fit testing required to select 
proper facepiece size
– Some eyewear may interfere with 
the fit 
Elastomeric half-
facepiece 
10 – Low maintenance
– Reusable facepiece and 
replaceable filters and 
cartridges
– No effect on mobility 
– Provides no eye protection
– Can add to heat burden
– Inward leakage at gaps in face 
seal
– Communication may be difficult
– Fit testing required to select 
proper facepiece size
– Some eyewear may interfere with 
the fit 
Powered with loose-
fitting facepiece 
25 – Provides eye protection
– Offers protection for 
people with beards, missing 
dentures or facial scars
– Low breathing resistance
– Flowing air creates cooling 
effect
– Face seal leakage is generally 
outward
– Fit testing is not required
– Prescription glasses can be 
worn
– Communication easier 
than with elastomeric half-
facepiece or full-facepiece 
respirators
– Reusable components and 
replaceable filters 
– Added weight of battery and 
blower
– Awkward for some tasks
– Battery requires charging
– Air flow must be tested with flow 
device before use 
(continued)
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Table 8–2 (Continued). Air-purifying particulate respirators 
Respirator 
type 
NIOSH 
assigned 
protection 
factor Advantages Disadvantages 
Elastomeric full-
facepiece with 
N-100, R-100, or 
P-100 filters
50 – Provides eye protection
– Low maintenance
– Reusable facepiece and 
replaceable filters and 
cartridges
– No effect on mobility
– More effective face seal than 
that of filtering facepiece or 
elastomeric half-facepiece 
respirators 
– Can add to heat burden
– Diminished field-of-vision 
compared to half-facepiece
–Inward leakage at gaps in face seal
–Fit testing required to select 
proper facepiece size
–Facepiece lens can fog without 
nose cup or lens treatment
–Spectacle kit needed for people 
who wear corrective glasses 
Powered with tight-
fitting half-facepiece 
or full-facepiece 
50 –Provides eye protection with 
full-facepiece
–Low breathing resistance
–Face seal leakage is generally 
outward
–Flowing air creates cooling 
effect
–Reusable components and 
replaceable filters 
–Added weight of battery and 
blower
–Awkward for some tasks
–No eye protection with half-
facepiece
–Fit testing required to select 
proper facepiece size
–Battery requires charging
–Communication may be difficult
–Spectacle kit needed for people 
who wear corrective glasses with 
full face-piece respirators
–Air flow must be tested with flow 
device before use 
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Occupational health surveillance is an essen-
tial component of an effective occupational 
safety and health program. The unique phys-
ical and chemical properties of nanomateri-
als, the increasing growth of nanotechnology 
in the workplace, and information suggesting 
that exposure to some engineered nanomate-
rials can cause adverse health effects in labo-
ratory animals all support consideration of 
an occupational health surveillance program 
for workers potentially exposed to engineered 
nanomaterials [Schulte et al. 2008a]. Contin-
ued evaluation of toxicologic research and 
workers potentially exposed to engineered 
nanomaterials is needed to inform NIOSH 
and other groups regarding the appropriate 
components of occupational health surveil-
lance for nanotechnology workers. 
NIOSH has developed interim guidance 
relevant to medical screening (one compo-
nent of an occupational health surveillance 
program) for nanotechnology workers (see 
NIOSH Current Intelligence Bulletin: In-
terim Guidance on Medical Screening and 
Hazard Surveillance for Workers Potentially 
Exposed to Engineered Nanoparticles, www.
cdc.gov/niosh/review/public/115/). Medical 
screening is only part of a complete safety 
and health management program that fol-
lows the hierarchy of controls and involves 
various occupational health surveillance 
measures. Since specific medical screening of 
workers exposed to engineered nanoparticles 
has not been extensively discussed in the sci-
entific literature, this document is intended 
to fill the knowledge gap on an interim basis. 
Increasing evidence indicates that exposure 
to some engineered nanoparticles can cause 
adverse health effects in laboratory animals, 
but no studies of workers exposed to the few 
engineered nanoparticles tested in animals 
have been published. The current body of 
evidence about the possible health risks of 
occupational exposure to engineered nano-
particles is quite small. Insufficient scien-
tific and medical evidence now exists to rec-
ommend the specific medical screening of 
workers potentially exposed to engineered 
nanoparticles. Nonetheless, the lack of evi-
dence on which to recommend specific 
medical screening does not preclude its con-
sideration by employers interested in tak-
ing precautions beyond standard industrial 
hygiene measures [Schulte et al. 2008b]. If 
medical screening recommendations ex-
ist for chemical or bulk materials of which 
nanoparticles are composed, they would ap-
ply to nanoparticles as well. 
Ongoing research on the hazards of engi-
neered nanoparticles is needed along with the 
continual reassessment of available data to 
determine whether specific medical screening 
is warranted for workers who are producing 
or using nanoparticles. In the meantime, the 
following recommendations are provided for 
the management of workplaces where em-
ployees may be exposed to engineered nano-
particles in the course of their work:
Take prudent measure to control work-•	
ers’ exposures to nanoparticles.
Conduct hazard surveillance as the ba-•	
sis for implementing controls.
Occupational Health Surveillance9
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Continue use of established medical •	
surveillance approaches.
NIOSH will continue to examine new re-
search findings and update its recommen-
dations about medical screening programs 
for workers exposed to nanoparticles. Ad-
ditionally, NIOSH is seeking comments on 
the strengths and weaknesses of exposure 
registries for workers potentially exposed to 
engineered nanoparticles. 
9 Occupational Health Surveillance
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NIOSH has developed a strategic plan for 
research on several occupational safety and 
health aspects of nanotechnology. The plan 
is available at www.cdc.gov/niosh/topics/
nanotech/strat_plan.html. NIOSH has fo-
cused its research efforts in the following 
10 critical topic areas to guide in addressing 
knowledge gaps, developing strategies, and 
providing recommendations. 
Exposure Assessment1. 
Determine key factors that influence  —
the production, dispersion, accumu-
lation, and re-entry of nano materials 
into the workplace.
Determine how possible expo- —
sures to nanomaterials differ by 
work process.
Assess possible exposure when  —
nanomaterials are inhaled or set-
tle on the skin.
Toxicity and Internal Dose2. 
Investigate and determine the  —
physical and chemical properties 
(e.g., size, shape, solubility, sur-
face area, oxidant generation po-
tential, surface functionalization, 
surface charge, chemical compo-
sition) that influence the poten-
tial toxicity of nanomaterials.
Determine the deposition pattern  —
of nanoparticles in the lung and 
their translocation to the interstiti-
um and to extrapulmonary organs.
Evaluate short- and long-term ef- —
fects of pulmonary exposure to 
nanomaterials in various organ 
systems and tissues (e.g., lungs, 
brain, cardiovascular).
Determine if intratracheal instil- —
lation or pharyngeal aspiration 
can mimic the biological response 
to inhalation exposure to nano-
materials.
Determine the dermal effects of  —
topical exposure to nano-objects, 
whether these nano-objects can 
penetrate into the skin, and whether 
they can cause immune alterations.
Determine the genotoxic and carci- —
nogenic potential of nano-objects.
Determine biological mechanisms  —
for potential toxic effects.
Determine whether in vitro screen- —
ing tests can be predictive on in 
vivo response.
Create and integrate models to  —
help assess potential hazards.
Determine whether a measure  —
other than mass is more appro-
priate for determining toxicity.
Epidemiology and Surveillance3. 
Evaluate existing exposure and  —
health data for workers employed 
in workplaces where nanoma-
terials are produced and used, 
with emphasis on improving our 
understanding of the value and 
Research Needs10
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utility of establishing exposure 
registries for workers potentially 
exposed to engineered nanoma-
terials. 
Assess the feasibility of industry- —
wide exposure and epidemiologi-
cal studies of workers exposed to 
engineered nanomaterials, with 
emphasis on workers potentially 
exposed to engineered carbona-
ceous nanomaterials.
Integrate nanotechnology safety  —
and health issues into existing haz-
ard surveillance mechanisms and 
continue reassessing guidance re-
lated to occupational health sur-
veillance for workers potentially 
exposed to engineered nanomate-
rials.
Build on existing public health  —
geographical information systems 
and infrastructure to enable effec-
tive and economic development 
of methods for sharing nanotech-
nology safety and health data. 
Risk Assessment 4. 
Determine how existing expo- —
sure-response data for fine and 
ultrafine particles (human or ani-
mal) may be used to identify the 
potential hazards and estimate 
the potential risks of occupational 
exposure to nanomaterials.
Develop a framework for assessing  —
the potential hazards and risks of 
occupational exposure to nano-
materials, using new toxicologic 
data on engineered nanomateri-
als and standard risk assessment 
models and methods.
Measurement Methods5. 
Evaluate methods used to measure  —
the mass of respirable particles in 
the air and determine whether 
this measurement can be used to 
measure nanomaterials.
Develop and field-test practical  —
methods to accurately measure 
airborne nanomaterials in the 
workplace. 
Develop, test, and evaluate systems  —
to compare and validate sampling.
Engineering Controls and Personal 6. 
Protective Equipment 
Evaluate the effectiveness of en- —
gineering controls in reducing 
occupational exposures to nano-
aerosols and developing new con-
trols when needed.
Evaluate the suitability of control- —
banding techniques when addi-
tional information is needed and 
evaluate the effectiveness of alter-
native materials.
Evaluate and improve current per- —
sonal protective equipment.
Develop recommendations (e.g.,  —
use of respiratory protection) to 
prevent or limit occupational ex-
posures to nanomaterials.
Fire and Explosion Safety7. 
Identify physical and chemical  —
properties that contribute to dusti-
ness, combustibility, flammability, 
and conductivity of nanomaterials.
10 Research Needs
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Recommend alternative work prac- —
tices to eliminate or reduce work 
place exposures to nanomaterials.
Recommendations and Guidance8. 
Use the best available science to  —
make interim recommendations for 
workplace safety and health prac-
tices during the production, use, 
and handling of nanomaterials.
Evaluate and update mass-based  —
occupational exposure limits for 
airborne particles to ensure good, 
continuing precautionary practices.
Communication and Information9. 
Establish partnerships to allow  —
for identification and sharing of 
research needs, approaches, and 
results.
Develop and disseminate train- —
ing and education materials to 
workers, employers, and occu-
pational safety and health pro-
fessionals.
 Applications10.
Identify uses of nanotechnology for  —
application in occupational safety 
and health.
Evaluate and disseminate effective  —
applications to workers, employ-
ers, and occupational safety and 
health professionals.
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1.0 Introduction
This appendix describes a technique that can 
be used by industrial hygienists for conduct-
ing initial workplace assessments for possible 
nanoparticle emissions. It allows a semi-
quantitative evaluation of processes and 
tasks in the workplace where releases of engi-
neered nanoparticles may occur. NIOSH uses 
several sampling approaches simultaneously 
with the goal of obtaining key physicochemi-
cal particle metrics: number concentration, 
qualitative size, shape, degree of agglomera-
tion, and mass concentration of elemental 
constituents of interest. 
2.0 Scope
Employers, workers, and researchers en-
gaged in the production and use of engi-
neered nanomaterials have expressed an 
interest in determining whether these nano-
materials are hazardous and if the potential 
for worker exposure exists. NIOSH has an 
active toxicology program to assess the po-
tential hazards of engineered nanoparticles. 
Unfortunately these studies require long 
time periods and fall behind the pace of pro-
duction and use of these nanomaterials. To 
assist in answering the latter of these ques-
tions, NIOSH established a nanotechnol-
ogy field research team tasked with visiting 
facilities and collecting information about 
the potential for release of nanomaterials 
and worker exposure at those facilities. The 
initial challenges that the field research team 
encountered were: 1) determining which 
exposure metric (e.g., mass, particle num-
ber concentration, particle surface area) for 
engineered nanoparticles would provide a 
consistent body of knowledge to align with 
the toxicological results observed in experi-
mental animal studies; and 2) selecting a 
sampling method based on metrics that 
were practical and would provide reproduc-
ible results. Engineered nanomaterials can 
be measured in the workplace using a vari-
ety of instrumentation including: condensa-
tion particle counter (CPC); optical particle 
counter (OPC); scanning mobility particle 
sizer (SMPS); electric low pressure impac-
tor (ELPI); aerosol diffusion charger; and 
tapered element oscillating microbalance 
(TOEM), which vary in complexity and field 
portability. Unfortunately, relatively few of 
the above instruments are readily applica-
ble to routine exposure monitoring due to 
non-specificity, lack of portability, difficulty 
of use, and high cost. NIOSH researchers 
have developed and used a field assessment 
strategy for determining exposures to engi-
neered nanoparticles that could be adopted 
by other health and safety professionals in 
the evaluation of occupational exposures 
[Methner, et. al. 2007; Methner, 2008]. 
Since there are currently no exposure lim-
its specific to engineered nanomaterials, 
this technique is used to determine whether 
Nanoparticle Emission Assessment Technique for Identification 
of Sources and Releases of Engineered Nanomaterials
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airborne releases of engineered nanomateri-
als occur. This assessment, which compares 
particle number concentrations and relative 
particle size at the potential emission source 
to background particle number concen-
trations and particle size, provides a semi-
quantitative means for determining the ef-
fectiveness of existing control measures in 
reducing engineered nanoparticle exposures. 
This procedure utilizes portable direct-read-
ing instrumentation supplemented by filter-
based air samples (source-specific and per-
sonal breathing zone [PBZ]). The use of filter 
samples is crucial for particle identification 
because direct-reading instruments used for 
determining particle number concentrations 
are incapable of identifying the composition 
of the particles. 
3.0 Summary of the On-Site 
Initial Assessment
The initial assessment uses a combination of 
direct-reading, handheld instruments (CPC 
and OPC) and filter-based sampling (e.g. 
37-mm diameter filter cassettes) for subse-
quent chemical and microscopic analyses 
(Figure 1). This semi-quantitative approach 
was first described by Maynard et al. [2004] 
and NIOSH has adopted a similar approach. 
The technique includes determining particle 
number concentration using direct-read-
ing, handheld particle counters at potential 
emission sources and comparing those data 
to background particle number concentra-
tions. If elevated concentrations of suspect-
ed nanoparticles are detected at potential 
emission sources, relative to the background 
particle number concentrations, then a pair 
of filter-based, source-specific air samples 
are collected with one sample analyzed by 
transmission electron microscopy (TEM) 
or scanning electron microscopy (SEM) for 
particle identification and characterization, 
and the other used for determining the el-
emental mass concentration (Figure 2). A 
second pair of filter-based air samples may 
also be collected in the personal breathing 
zone of workers. Breathing zone samples are 
analyzed in the same manner as the area air 
samples (i.e., by TEM and elemental mass).
4.0 Air Sampling 
Instrumentation and Filter 
Media Used in the Initial 
Assessment 
The following instrumentation is used by 
NIOSH; however, use does not constitute 
endorsement. 
4.1 TSI model 3007 (or model 8525) (TSI 
Inc, Shoreview, MN), handheld con-
densation particle counter (CPC), 
which uses isopropanol to condense 
on particles so they can be counted
 The TSI units provide a non-spe-
cific measure of the total number 
of particles independent of chemi-
cal identity per cubic centimeter of 
air (P/cm3). The measureable range 
is between 10–1,000 nm for model 
3007, or between 20–1,000 nm for 
model 8525. The range of detec-
tion for these instruments is re-
ported by the manufacturer to be 
0–100,000 P/cm3.
4.2 ART Instruments Hand Held Particle 
Counter (HHPC-6, ART Instruments, 
Grants Pass, Oregon), which operates 
on optical counting principles using 
laser light scattering.
 The HHPC-6 optical particle coun-
ter (OPC) can measure the total 
number of particles per liter (P/L) 
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of air independent of chemical iden-
tity within six specific size ranges. 
The OPC used by the NIOSH field 
research team provides particle 
counts in the following size cut-
points: 300 nm; 500 nm; 1,000 nm; 
3,000 nm; 5,000 nm; and 10,000 nm. 
The range of detection for this instru-
ment is reported by the manufacturer 
to be 0−70,000 P/L. Different manu-
facturers’ OPCs may have slightly dif-
ferent particle size ranges and could 
be substituted.
4.3 Appropriate air sampling filter media 
(e.g. mixed cellulose ester, quartz fi-
ber filter) are selected depending on 
nanoparticle type and desired analyt-
ical information (e.g., determination 
of particle morphology using TEM 
or SEM, elemental analysis for met-
als, elemental analysis for carbon) 
4.4 Air sampling pumps capable of sam-
pling at high flow rates (e.g., 7  liters 
per minute or other flow rate depend-
ing upon the duration of the task and 
the appropriate NIOSH method, if a 
method is available)
4.5 Sampling pump flow calibrator
4.6 If desired, personal cascade impactor 
or respirable cyclone (see 5.3.3)
4.7 If desired, cassette conductive cowl 
(see 5.3.3)
4.8 Optional research-grade particle 
analyzers for expanded surveys (see 
5.6.1)
4.9 Optional surface sampling sup-
plies such as substrate (e.g., Ghost 
Wipes™), disposable 10 cm × 10 
cm templates, sterile containers, and 
nitrile gloves for handling media (see 
5.6.2)
5.0 Evaluation of Potential 
Releases of Engineered 
Nanomaterials
5.1 Identify Potential Sources of 
Emissions
 The overall purpose of this step is to 
develop a list of target areas and tasks 
that will be evaluated with the par-
ticle analyzers. 
 The initial assessment involves iden-
tifying the potential sources of en-
gineered nanomaterial emissions by 
reviewing the type of process, process 
flow, material inputs and discharges, 
tasks, and work practices. When 
available, literature (e.g., MSDS, re-
cords of feedstock materials) is re-
viewed to gain an understanding of 
the engineered nanomaterials being 
produced or used, including their 
physicochemical properties such as 
size, shape, solubility, and reactivity. 
Once the potential sources of emis-
sions have been identified from the 
process review, the industrial hygien-
ist (or other qualified person): 
Conducts an observational walk-•	
through survey of the produc-
tion area and processes to locate 
potential sources of emissions.
Determines the frequency and •	
duration of each operation and 
the type of equipment used for 
handling and containment of 
the material.
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Determines the presence/absence •	
of general and local exhaust ven-
tilation and other engineering 
controls. (This initial assess-
ment includes identifying points 
of potential system failure that 
could result in emission from 
the containment/control system 
[e.g., hole in duct, deteriorated 
sealing gasket]).
Determines the process points •	
where containment is deliber-
ately breached (e.g., opening 
system for product retrieval or 
for cleaning).
5.2 Conduct Particle Concentration 
Sampling
5.2.1 Background measurements
 Determining the contribution of 
background particle concentrations 
on measurements made for the parti-
cles of interest (e.g., engineered nano-
particles) is an important evaluation 
of assessing the possible airborne re-
lease of engineered nanoparticles.
 Ideally, during the initial assessment, 
the industrial hygienist (or other qual-
ified person), will determine the aver-
age airborne particle concentration at 
various processes and adjacent work 
areas with the CPC and OPC before 
the processing or handling of nano-
materials begins. If the background 
particle concentrations are high (val-
ues are relative and will vary with pro-
cesses and facilities), an assessment 
is made as to whether there may be a 
source of incidental nanoparticles in 
the area. Incidental nanoparticles may 
be generated from a variety of sources, 
including vacuum pumps, natural gas 
heating units, gasoline/propane/die-
sel powered fork lift trucks, or other 
combustion activities such as welding, 
soldering, or heat-sealing. The CPC 
and OPC can be used to check these 
sources for incidental nanoparticle 
releases. Outdoor or re-circulated air 
supply from the building ventilation 
system should also be considered as a 
possible source of nanoparticles [Pe-
ters et al. 2006]. 
 Measurements of background parti-
cle concentrations are repeated after 
the active processing, manufacturing, 
or handling of the nanomaterial has 
ended. An average background con-
centration is then computed and sub-
tracted from the measurements made 
during processing, manufacturing, or 
the handling of engineered nanoma-
terials. This approach is acceptable 
only if background particle counts 
remain relatively stable throughout 
the measurement period and particle 
emissions from the process under in-
vestigation are sufficiently elevated 
above background. For other situ-
ations, correcting for particle back-
ground concentrations becomes 
more complex requiring additional 
sampling over an extended time pe-
riod to determine the source(s) and 
magnitude of background particle 
concentrations. This type of evalua-
tion is generally outside the scope of 
the initial assessment described here.
5.2.2 Area sampling
 Once initial background particle con-
centrations have been determined, 
measurements of airborne particle 
concentrations and size ranges are 
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made with the CPC and OPC simul-
taneously at locations near the sus-
pected or likely emission source (e.g., 
opening a reactor, handling product, 
potential leak points in the ventila-
tion system). Airborne particle con-
centrations are determined before, 
during, and after each task or opera-
tion to identify those factors (e.g., 
controls, worker interaction, work 
practices) that may affect airborne 
particle concentrations. This infor-
mation is used to identify processes, 
locations, and personnel for filter-
based air sampling (5.3).
5.3 Conduct Filter-based Area and 
Personal Air Sampling
5.3.1 Area air sampling
 A pair of filter-based, air samples are 
collected at process/task locations 
and/or workers engaged in process 
operations where suspected engi-
neered nanomaterial emissions may 
occur, based on air sampling results 
using the CPC and OPC. 
 Filter-based area air samples provide 
more specific information on the 
engineered nanomaterial of inter-
est (e.g., size, shape, mass). The pair 
of air samples includes one sample 
analyzed for elemental mass and one 
sample analyzed by electron micros-
copy. For example, one sample might 
be collected for metals determination 
(e.g., NIOSH Method 7300, 7303) 
or elemental carbon (e.g., NIOSH 
Method 5040) depending on the 
composition of the engineered nano-
material. The other sample would be 
collected for particle characterization 
(e.g., size, shape, dimension, degree 
of agglomeration) by TEM or SEM 
using the measurement techniques 
specified in NIOSH Methods 7402, 
7404, or other equivalent methods 
[NIOSH 1994]. 
 The source-specific air samples are 
collected as close as possible to the 
suspected emission source but out-
side of any existing containment, to 
increase the probability of detecting 
any possible release of engineered 
nanomaterials. Sampling duration 
generally matches the length of time 
in which the potential exposure to the 
engineered nanomaterial exists at the 
task or specific process. In cases where 
the duration of the tasks associated 
with the potential airborne release 
of nanomaterials is short (e.g., min-
utes), a relatively high air sampling 
flow rate may be required (approxi-
mately 7 liters per minute) to ensure 
adequate particle loading on the filter 
media. If specific information is de-
sired on the worker’s potential expo-
sure to the engineered nanomaterial 
then PBZ samples should be collect-
ed using the two- sample filter-based 
sampling strategy described above.
 If the particle number concentrations 
(using CPC or OPC) are substantially 
high, then shorter sampling times for 
the TEM or SEM sample may be nec-
essary to avoid overloading the filter 
and interfering with particle charac-
terization. The specific sampling time 
should be based on direct-reading 
instrument results and professional 
judgment of the industrial hygien-
ist. In general, filter samples are col-
lected for the duration of a given 
task, normally 15–30 minutes. If the 
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 direct-reading instruments indicate a 
high particle number concentration 
the sampling time can be shortened 
to 5–10 minutes, or both a short- and 
long-duration sample may be col-
lected to ensure an adequate sample 
for electron microscopy analysis. See 
Table 1 for additional sampling time 
guidance. However, the sampling 
times in Table 1 were based on col-
lection of asbestos fibers by NIOSH 
Method 7402 and may not be appli-
cable for much smaller engineered 
nanoparticles. See Figures 3–5 for ex-
ample TEM micrographs.
 A minimum of 2 background filter 
samples are collected distant from 
the potential sources of engineered 
nanoparticle exposure to serve as an 
indicator of ambient particle identi-
fication and concentration.
5.3.2 Personal air samples
 When possible, personal breathing 
zone (PBZ) air samples are collected 
on workers likely to be exposed to en-
gineered nanomaterials (e.g., engaged 
in active handling of nanomaterials 
or operating equipment previously 
identified as emitting nanoparticles). 
If measurements obtained with the 
CPC and OPC indicate that nano-
particles are being emitted at a specif-
ic process where a worker is located, 
then the collection of PBZ samples 
may be warranted.
 PBZ samples are analyzed in the 
same manner as the area air samples 
(i.e., by TEM and elemental mass). It 
may be necessary to collect samples 
at a relatively high flow rate (e.g., 7 
liters per minute) if the duration of 
the task and the resulting potential 
exposure is short. 
5.3.3 Optional sample collection
 In the event that measurements 
made by the OPC indicate a large 
fraction (over 50%) of particles ex-
ceeding 1,000 nm in size, the use of 
a personal cascade impactor or respi-
rable cyclone sampler in tandem with 
a filter-based air sampling cassette 
may be required for both the mass 
and TEM/SEM analyses to eliminate 
large particles that may interfere with 
analysis and be of limited interest. 
The use of an impactor or cyclone 
will require using a flow rate appro-
priate for the particle cut size and is 
usually in the range of 1.7–2.5 liters 
per minute. Open-face, and impactor 
or cyclone samples may be collected 
side by side to allow a more thorough 
interpretation of analytical results. 
Additionally, if it is anticipated that 
the nanoparticles of interest will have 
a tendency to be electrostatically at-
tracted to the sides of the plastic air 
sampling cassette, a conductive cowl 
may be necessary to eliminate par-
ticle loss and subsequent underesti-
mation of the airborne nanoparticle 
concentration. The use of a personal 
cascade impactor, respirable cyclone, 
or conductive cowl is made at the dis-
cretion of the industrial hygienist (or 
other qualified person). 
 If the facility is manufacturing or us-
ing TiO
2
, then  the  sampling  should  in-
clude the sampling recommendations 
found in the NIOSH Draft Document: 
Evaluation of Health Hazard and Recom-
mendations for Occupational Exposure 
to Titanium Dioxide (www.cdc.gov/
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niosh/review/public/TiO2/default.
html),which recommends collecting 
a mass-based airborne measurement 
using NIOSH Method 0600. 
5.4 Quality Assurance and Quality 
Control
 To ensure valid emission measure-
ments, the following quality assurance 
and control steps should be taken: 
Use factory calibrated direct-•	
reading particle analyzers
Perform daily zero-checks on all •	
particle counters before each use
Calibrate pumps before and af-•	
ter each sampling day
Submit for analysis any process, •	
background, and bulk mate-
rial samples along with field 
and media blanks to a labora-
tory accredited by the American 
Industrial Hygiene Association 
(AIHA)
5.5 Data Interpretation
 Since the size of airborne engineered 
nanoparticles and the degree of ag-
glomeration may be unknown at 
the time of sample collection, the 
use of direct-reading, particle sizing/
counting instruments may provide a 
semi-quantitative indication of the 
magnitude of potential emissions, 
provided background particle num-
ber subtraction can be successfully 
accomplished. The particle number 
concentration measurements taken 
with the CPC and OPC will provide a 
measurement of particles larger than 
the ASTM definition of nanoparticles 
(1–100 nm) [ASTM 2006]. However, 
the two particle counters can be used 
simultaneously to obtain a semi-
quantitative size differential evalu-
ation of the aerosol being sampled. 
The CPC provides a measure of to-
tal particles per cm3 in the size range 
of 10–1,000 nm (or 20–1,000 nm). 
The OPC provides the total number 
of particles per liter of air within six 
specific size ranges: 300 nm; 500 nm; 
1,000 nm, 3,000 nm, 5,000 nm and 
> 10,000 nm. If necessary, the data 
from the CPC and OPC can be used 
together to determine the number 
concentration of nanoscale particles. 
For example, a high particle number 
concentration on the CPC, in com-
bination with a high particle num-
ber concentration in the small size 
ranges (300–500 nm) on the OPC, 
may indicate the possible presence of 
nanoscale particles. Conversely, a low 
CPC particle number concentration, 
in combination with a high OPC 
particle number concentration in the 
larger size ranges (> 1,000 nm) may 
indicate the presence of larger par-
ticles and/or engineered nanoparticle 
agglomerates. These assumptions of 
nanoparticles versus larger particles 
and/or nanoparticle agglomerates 
may be verified by TEM or SEM anal-
ysis.
5.5.1  Selectivity
 Selectivity is a critical issue when 
characterizing exposure using air-
borne particle number concentration. 
Airborne nanoparticles are present 
in many workplaces and often origi-
nate from multiple sources such as 
combustion, vehicle emissions, and 
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infiltration of outside air. Particle 
counters are generally not selective to 
particle source or composition, mak-
ing it difficult to differentiate between 
incidental and process-related nano-
particles using number concentration 
alone. The CPC and OPC are used to 
identify sources of nanoparticles and 
the filter-based samples are used to 
verify the size, shape, and chemical 
composition of the nanoparticles with 
the goal of differentiating between 
incidental and engineered nanopar-
ticles.
5.5.2  Limitations
 The exposure assessment technique 
does have some limitations includ-
ing:
Although this issue is not unique •	
to particle number concentra-
tion measurements, orders of 
magnitude difference can exist 
in aerosol number concentra-
tions, depending on the number 
and types of sources of particle 
emissions. Monitoring over sev-
eral days and during different 
seasons can provide a better un-
derstanding of the variability that 
might exist in airborne particle 
number concentrations found 
in background measurements 
and in measurements made at 
sources where engineered nano-
materials are handled. 
The upper dynamic range of •	
the CPC is 100,000 P/cm3. A 
dilutor, consisting of a modi-
fied HEPA filter cartridge placed 
upstream of the inlet, can ex-
tend the range of the CPC when 
particle number concentrations 
are greater than 100,000 P/cm3 
[Peters et al. 2006; Heitbrink et 
al. 2007; Evans et al. 2008].
The analysis of air samples by •	
TEM or SEM with energy dis-
persive X-ray spectrometry can 
provide information on the el-
emental composition of the 
nanomaterials. However, TEM 
and SEM analysis can be com-
promised if there is particle 
overload on the filter. Alterna-
tively, if the loading is too sparse, 
an accurate assessment of par-
ticle characteristics may not be 
possible (see 5.3.1).
Note that area samples are col-•	
lected as closely as possible to 
the source of emission to allow 
for more accurate determination 
of a nanoparticle release and to 
identify locations most likely 
to result in worker exposure. 
Therefore, results from this 
type of sampling should not be 
interpreted as representative 
of worker exposure. However, 
samples collected in such a fash-
ion should serve as an indicator 
of material release and the pos-
sible need for controls.
5.6  Expanded Research (In Depth 
Assessments)
5.6.1 Research instrumentation
 A major obstacle in conducting more 
specific measurement of engineered 
nanomaterials in the workplace is a 
lack of field-portable instruments 
that can be easily maneuvered within 
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a facility or easily worn by a worker to 
provide an indication of PBZ expo-
sure. Additionally, there is no single 
instrument capable of measuring the 
numerous potential exposure metrics 
associated with engineered nanoma-
terials (e.g., number concentration, 
surface area, size, shape, mass concen-
tration) [Maynard and Aitken 2007]. 
Although the following instruments 
lack field portability and ease of use, 
they can measure many of the desir-
able exposure metrics and provide 
information about the particle size 
distribution. These research-grade 
particle analyzers are not usually part 
of the initial assessment but are used 
when additional knowledge about 
the nanoscale particle temporal or 
spatial exposure variation or size dis-
tribution is desired.
5.6.1.1 Particle Surface-Area Analyzers
 Toxicology studies have indicated that 
surface area of nanoparticles may be 
an important exposure dose metric. 
Portable aerosol diffusion chargers 
may be used to provide estimates of 
external aerosol surface area when 
airborne particles are smaller than 
100 nm in diameter, but these may 
tend to overestimate external surface 
area when particles are larger than 
100 nm in diameter. These instru-
ments are based on diffusion charging 
followed by detection of the charged 
aerosol using an electrometer.
 The TSI Aerotrak™ 9000 Nanoparticle 
Aerosol Monitor does not measure to-
tal active surface area but indicates the 
surface area of particles which may be 
deposited in the lung in units of square 
micrometers per cubic centimeter, 
corresponding to either the tracheo-
bronchial or alveolar regions of the 
lung. The Ecochem DC 2000-CE 
measures the total particle surface 
area. These devices are currently being 
evaluated as part of the process used 
by NIOSH to conduct initial assess-
ments. These particle surface analyz-
ers are used as area samplers.
5.6.1.2. Scanning Mobility Particle Sizer
 More specific depictions of particles 
by size (diameter) and number can 
greatly improve the ability to evaluate 
possible releases of engineered nano-
particles. One particular instrument, 
the Scanning Mobility Particle Sizer 
(SMPS) measures particle diameters 
from 2.5–1,000 nm and can display 
data as a size and number distribu-
tion using up to 167 size channels. 
The SMPS is widely used as a re-
search tool for characterizing nano-
scale aerosols. The SMPS employs a 
continuous, fast-scanning technique 
to provide high-resolution measure-
ments. However, the SMPS may take 
2–3 minutes to scan which may not 
be useful for the process screening in 
workplaces with highly variable aero-
sol size distributions. Its applicability 
for use in the workplace may be lim-
ited because of its size, cost, and use 
of an internal radioactive source.
 The Fast Mobility Particle Sizer 
(FMPS) is similar to the SMPS but has 
a much faster response time (approx-
imately 1 second). However, because 
it has fewer particle size channels, it 
does not include the same level of de-
tail on particle size distributions that 
can be determined with the SMPS. 
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The FMPS and SMPS are used as area 
samplers.
5.6.1.3 Low Pressure Impactors
 The Electrical Low Pressure Impactor 
(ELPI) combines diffusion charging 
and a cascade impactor to provide 
aerosol size distributions by aerody-
namic diameter as determined real 
time by mass and number collected 
on a series of plates.
 Low pressure cascade impactors offer 
the ability to size particles and then 
conduct secondary analyses (e.g., 
metals analysis). However, these in-
struments are sensitive to harsh field 
conditions and are not considered 
portable. The ELPI is used as an area 
sampler. 
5.6.1.4 Tapered Element Oscillating Mi-
crobalance
 The tapered element oscillating mi-
crobalance (TEOM) is commonly 
used for sampling aerosols less than 
1 µm in diameter, however, the sam-
pling inlet can be set to select different 
size fractions. The TEOM determines 
mass by detecting a change in vibra-
tion frequency across a particle-col-
lecting substrate. The TEOM can be 
configured to provide size-differenti-
ated mass measurements and is used 
as an area sampler.
5.6.2 Surface sampling
 Surface sampling to detect the pres-
ence of engineered nanomaterials is 
not routinely part of the initial assess-
ment but may be conducted to deter-
mine if surface contamination exists. 
Surface sampling does not provide 
size-specific information but may be 
useful for determining whether engi-
neered nanomaterials have migrated 
away from active production or han-
dling areas and have contaminated 
nonproduction work areas. The de-
cision to collect surface samples is 
made in the field at the discretion 
of the industrial hygienist (or other 
qualified person), and is dependent 
on direct observation and the nano-
material of interest. For example, 
surface sampling was completed at 
a quantum dot facility after observ-
ing dusty surfaces in areas adjacent to 
the production area. In order to de-
termine if the dust was contaminated 
with quantum dots, surface samples 
were collected and analyzed for the 
chemical components of the quan-
tum dots produced by that facility. 
 Surface wipe samples are collected 
using a pre-moistened substrate such 
as Ghost Wipe™ towelettes in ac-
cordance with NIOSH Method 9102 
for elements or the NIOSH method 
for specific elements (e.g., NIOSH 
Method 9100 for lead). When collect-
ing wipe samples, the following steps 
should be followed:
Don a pair of nitrile disposable •	
gloves
Wipe the surface within a dispos-•	
able 10 cc × 10 cc template using 
four horizontal s-shaped strokes
Fold the exposed side of the wipe •	
in and wiping the same area with 
four vertical s-shaped strokes
Fold the wipe, exposed side in, and •	
placing it into a sterile container
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 Gloves and template are discard-
ed after each sample collection to 
eliminate the possibility of cross-
contaminating successive samples. 
Wipe samples may be collected from 
undisturbed horizontal surfaces 
throughout the facility at locations 
suspected to be contaminated and 
in areas expected to be free of engi-
neered nanomaterials. Wipe samples 
are analyzed following the appropri-
ate NIOSH method for the chemical 
substance of interest.
6.0 Conclusions
 The NIOSH initial assessment tech-
nique uses complimentary approaches 
to semi-quantitatively evaluate the po-
tential releases of engineered nanopar-
ticles. Two different particle counters 
are used in a parallel and differential 
manner to evaluate the total particle 
number relative to background and 
the relative size distribution of the 
particles. If this initial evaluation in-
dicates an elevated number of small 
particles, which could potentially be 
the engineered nanoparticle of inter-
est, then the particle counters are used 
to detect the source of the emissions. 
If nanoparticles are found and deter-
mined to be emitted from a specific 
process (versus background incidental 
nanoscale particles), then additional 
samples are collected for qualitative 
measurement of particle size and 
shape, (by TEM or SEM analysis) and 
for determination of elemental mass 
concentration (by chemical analysis). 
 The initial assessment technique 
is useful for determining wheth-
er airborne releases of engineered 
nanomaterials are occurring at po-
tential emission sources. This assess-
ment provides a semi-quantitative 
means for determining whether ex-
isting measures are adequate for con-
trolling nanomaterial emissions or if 
additional controls may be required. 
 The NIOSH emission assessment 
technique may be useful to health 
and safety professionals who are in-
terested in determining whether re-
lease of nanomaterials occurs in the 
workplace. Where possible, use of 
the technique should be repeated 
in workplaces of interest to gain a 
better understanding of the daily 
fluctuations in airborne exposures 
at processes and tasks in which en-
gineered nanomaterials occur and 
for determining potential sources of 
background particle number concen-
trations. A more systematic and rou-
tine assessment of the workplace can 
provide more definitive information 
on the performance of control mea-
sures and if additional actions are 
needed to reduce worker exposure. 
 The initial assessment technique can 
be expanded or modified to determine 
additional metrics (Figure 6). Research 
initiatives addressing more compre-
hensive process monitoring, particle 
metrics, personal exposure monitoring, 
and method/approach development 
and validation are currently underway 
within NIOSH. As this information 
becomes available, revisions to the Ap-
proaches to Safe Nanotechnology doc-
ument will be made. 
 Information about contacting the 
nanotechnology field research team 
is available at: [www.cdc.gov/niosh/
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docs/2008-121], see the Fact Sheet: 
NIOSH Nanotechnology Field Re-
search Effort [NIOSH 2008]. 
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Table 1. Approximate sampling times for TEM grid based on particle 
number concentrations*.
Open-faced cassettes
TEM grid 25-mm 37-mm 47-mm
Diameter (mm)  3.0 25.0 37.0 47.0
Effective diameter (mm)  3.0 22.2 34.2 44.2
Effective collection area 
(mm2)
 7 385 916 1531
Flow (L/min)  0.1 7 7 7
Desired Loading (#/mm2) 1.E+06 1.E+06 1.E+06 1.E+06
Air concentration 
(#/cm3) Time (min)
  250   282.7   220.2   523.4   874.8
  500   141.4   110.1   261.7   437.4
  1,000   70.7   55.0   130.8   218.7
  2,000   35.3   27.5   65.4   109.4
  4,000   17.7   13.8   32.7   54.7
  8,000   8.8   6.9   16.4   27.3
  16,000   4.4   3.4   8.2   13.7
  32,000   2.2   1.7   4.1   6.8
  64,000   1.1   0.9   2.0   3.4
  128,000   0.6   0.4   1.0   1.7
*NIOSH NMAM Method 7402 Asbestos by TEM and personal communication with 
Dr. Aleksandr Stefaniak (NIOSH)
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Figure 1. A demonstration of the initial assessment 
technique with side-by-side sampling using (from left 
to right) the OPC, co-located open-face filter cassettes, 
and the CPC: examples of PBZ and source-specific 
filter-based sampling setup.
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Figure 2. Summary of the initial assessment technique
Figure 4. Electron microscopy micrograph 
of a carbon nanofiber and carbon 
nanotube
Figure 3. Electron microscopy micrograph 
of a carbon nanofiber
Carbon Nanotube
Carbon Nanofiber
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Figure 5. Electron microscopy micrograph of an 
agglomerated nanoparticle of nickel oxide
Figure 6. Considerations for expanded nanomaterial assessments
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